Recherche Images Maps Play YouTube Actualités Gmail Drive Plus »
Connexion
Les utilisateurs de lecteurs d'écran peuvent cliquer sur ce lien pour activer le mode d'accessibilité. Celui-ci propose les mêmes fonctionnalités principales, mais il est optimisé pour votre lecteur d'écran.

Brevets

  1. Recherche avancée dans les brevets
Numéro de publicationUS20040096959 A1
Type de publicationDemande
Numéro de demandeUS 10/432,827
Numéro PCTPCT/GB2001/005634
Date de publication20 mai 2004
Date de dépôt19 déc. 2001
Date de priorité19 déc. 2000
Autre référence de publicationCA2432452A1, CA2432452C, CA2432535A1, CN1292703C, CN1491358A, CN1499949A, CN100458441C, DE60141252D1, EP1350099A1, EP1350099B1, EP1359837A1, EP1359837B1, EP1769735A1, EP1769735B1, EP2305102A1, EP2305102B1, US7005857, US20040072357, WO2002049507A1, WO2002050534A1, WO2002050534A9
Numéro de publication10432827, 432827, PCT/2001/5634, PCT/GB/1/005634, PCT/GB/1/05634, PCT/GB/2001/005634, PCT/GB/2001/05634, PCT/GB1/005634, PCT/GB1/05634, PCT/GB1005634, PCT/GB105634, PCT/GB2001/005634, PCT/GB2001/05634, PCT/GB2001005634, PCT/GB200105634, US 2004/0096959 A1, US 2004/096959 A1, US 20040096959 A1, US 20040096959A1, US 2004096959 A1, US 2004096959A1, US-A1-20040096959, US-A1-2004096959, US2004/0096959A1, US2004/096959A1, US20040096959 A1, US20040096959A1, US2004096959 A1, US2004096959A1
InventeursMatthias Stiene, Tanja Richter, John Allen, Jerome McAleer
Cessionnaire d'origineMatthias Stiene, Tanja Richter, John Allen, Mcaleer Jerome
Exporter la citationBiBTeX, EndNote, RefMan
Liens externes: USPTO, Cession USPTO, Espacenet
Analyte measurement
US 20040096959 A1
Résumé
A glucose sensor in the form of a skin patch 2 has a microneedle 4 which painlessly penetrates the skin to draw out interstitial fluid. The interstitial fluid passes to a common entrance port 7. A series of microchannels 8 is provided on the skin patch. The fluid drawn onto the patch is selectively switched between a number of microchannels 8 by means of electro-osmotic pumps 10 and hydrophobic gates 12. Each microchannel 8 has an electrochemical detector 11 for sensing gluocse concentration.
Also disclosed is a monlithic device with an integrated lance 83.
Images(10)
Previous page
Next page
Revendications(176)
1. A device for measuring the concentration of an analyte in a fluid, comprising a support member and a plurality of analyte sensing means provided thereon for measuring said concentration, wherein said device further comprises a plurality of conduits such that each of said sensing means has a conduit associated therewith, said conduits serving in use to direct said fluid to respective sensing means.
2. A device as claimed in claim 1 comprising a penetration member, preferably integrally formed, sufficiently short only to penetrate the cutaneous layer of skin, most.
3. A device as claimed in claim 1 or 2 comprising at least one microchannel for conveying a interstitial fluid to one or more of the sensing means.
4. A device as claimed in claim 1, 2 or 3 wherein at least some of said sensing means are the same or are for measuring the same analyte.
5. A device as claimed in claim 4 which is arranged such that in use the plurality of sensing means take measurements of the fluid at different times to enable monitoring of the concentration of the analyte in the fluid over a period of time.
6. A device for measuring the concentration of an analyte in a fluid, comprising a support member, analyte sensing means provided thereon for measuring said concentration and a microchannel in fluid communication with said analyte sensing means for conveying said fluid to said sensing means.
7. A device as claimed in claim 6 wherein the analyte sensing means comprises one or more reagents to react with said analyte and thereby give a measurable output.
8. A device as claimed in claim 7 wherein the reagent or at least one of the reagents is provided on a wall of the microchannel.
9. A device for measuring the concentration of an analyte in a fluid, comprising a support member and a microchannel provided on said support member for conveying said fluid across the support member, wherein one or more reagents for reacting with said analyte is coated on a wall of the microchannel.
10. A device as claimed in claim 9 comprising means for measuring the output of a reaction between the analyte and the reagent.
11. A device as claimed in any preceding claim comprising integral fluid extraction means for extracting a body fluid from a human of animal body fluid.
12. A device for measuring the concentration of an analyte in a fluid, comprising a support member, means provided on the support member for sensing said analyte, wherein said support member further comprises fluid extraction means arranged to direct fluid to said analyte sensing means via a conduit on the support member.
13. A device as claimed in claim 12 wherein said conduit comprises a microchannel.
14. A device as claimed in claim 11, 12 or 13 wherein said fluid extraction means comprises a skin penetration member.
15. A device as claimed in claim 14 wherein said skin penetration member is of such a length that it penetrates only the cutaneous layer of skin, not the sub-cutaneous layer.
16. A device as claimed in claim 15 wherein said skin penetration member is adapted to extract interstitial fluid.
17. A device for measuring the concentration of an analyte in a bodily fluid, comprising skin penetration means, said penetration means being sufficiently short so as to penetrate only the cutaneous layer of skin without penetrating the sub-cutaneous layer, and a support member, said support member comprising an analyte sensing site and a microchannel for conducting said body fluid from said penetration member to said analyte sensing site.
18. A device as claimed in claim 17 wherein said penetration means is integral with said support layer.
19. A device as claimed in any of claims 14 to 18 comprising a microneedle for extracting interstitial fluid.
20. A device as claimed in any preceding claim which is adapted to measure glucose concentration.
21. A device as claimed in any preceding claim comprising analyte sensing means including a mediated amperometric enzyme electrode.
22. A device as claimed in claim 21 adapted to utilise ferrocene-mediated electron transfer from a glucose-oxidase catalysed reaction.
23. A device as claimed in any preceding claim comprising a plurality of analyte sensing means.
24. A device as claimed in any preceding claim which is arranged to measure an analyte concentration directly.
25. A device as claimed in any preceding claim which is suitable for attachment to the skin of a subject for measuring the concentration of an analyte in blood or interstitial fluid of the subject.
26. A device as claimed in claim 25 comprising means for attaching the device to the skin.
27. A device for measuring the concentration of a given analyte in a body fluid comprising means for attaching the device to the skin of a subject and a plurality of sensing means for making a plurality of measurements of said concentration over a period of time.
28. A device as claimed in any preceding claim arranged to take measurements at predetermined intervals.
29. A device as claimed in claim 28 comprising flow control means for influencing the flow of fluid to the sensing means.
30. A device as claimed in claim 29 wherein the flow control means comprises a hydrophobic gate disposed in a microchannel.
31. A device as claimed in claim 30 comprising means for changing the hydrophobicity of said gate.
32. A device as claimed in claim 31 comprising a hydrophilic base material covered by a hydrophobic material and further comprising means for exposing said hydrophilic base material.
33. A device as claimed in claim 30 comprising pumping means arranged to apply a pressure to liquid in said microchannel sufficient to breach said hydrophobic gate.
34. A device as claimed in any preceding claim comprising a plurality of analyte sensing means, said device being arranged to direct fluid sequentially to each of the sensing means.
35. A device as claimed in claim 34 comprising or being adapted to interface with, control means for generating signals to control said direction of the fluid to the sensing means.
36. A device as claimed in claim 35 comprising said control configured so as to allow a user to specify when a measurement is to be made.
37. A device as claimed in claim 35 or 36 comprising calorimetric transduction means.
38. A device as claimed in any of claims 34 to 37 comprising a common fluid collection region arranged so as in use to be in fluid communication with a body fluid to be measured.
39. A device as claimed in claim 38 wherein each of said sensing means is in selective fluid communication with said common collection region.
40. A device for making a plurality of measurements of the concentration of an analyte in a fluid comprising a common sample collection site in fluid communication with the fluid to be measured and a plurality of sensing means for measuring said concentration.
41. A device as claimed in any of claims 34 to 40 comprising a sensing means for making a substantially continuous measurement of the concentration of a substance.
42. A device for measuring the concentration of an analyte in a fluid comprising a sensing means for measuring said concentration substantially continuously and calibration sensing means for performing at least one calibration measurement.
43. A device as claimed in claim 42 comprising a plurality of individual sensing means to allow a series of periodic calibration measurements to be performed.
44. A device as claimed in claim 44 wherein the continuous sensing means and calibration sensing means are provided on a common base member.
45. A device as claimed in claim 44, wherein said common base member comprises a patch or the like for attachment to the skin of a user.
46. A device as claimed in any of claims 42 to 45 comprising flow control means associated with fluid conduits for conducting fluid to the calibration sensing means.
47. A device as claimed in claim 46 wherein said flow control means comprises an electro-osmotic pumping arrangement.
48. A device as claimed in any of claims 42 to 47 which is suitable for attachment to a user's skin.
49. A device as claimed in any of claims 42 to 48 wherein said calibration sensing means comprises a single use sensor.
50. A device as claimed in any of claims 42 to 49 wherein said calibration sensing means is downstream of the continuous sensing means.
51. A device as claimed in any of claims 42 to 50 comprising one or more microchannels for conveying the fluid to be measured to the sensing means.
52. A device as claimed in any preceding claim which is suitable for attachment to a user's skin comprising transfer means for transferring said a body fluid from the user's body to a sensitive part of the device.
53. A device as claimed in claim 52 wherein said transfer means is arranged to transfer a fluid to the upstream end of a microchannel.
54. A device as claimed in claim 52 or 53 wherein said transfer means comprises a needle.
55. A device as claimed in claim 54 wherein said needle is a microneedle of such a length that it penetrates the cutaneous layer of skin, but not the sub-cutaneous layer.
56. A device as claimed in claim 54 or 55 wherein the needle comprises an aperture on a side surface thereof.
57. A device as claimed in any of claims 52 to 56 wherein said transfer means is invasive or semi-invasive, the device further comprising means for applying pressure to the user's skin in the region of penetration by said transfer means.
58. A device as claimed in any preceding claim comprising display means for displaying the concentration of an analyte being measured.
59. A device as claimed in claim 58 wherein said display means is separate from the rest of the device and receives data therefrom by telemetry.
60. A device as claimed in any preceding claim comprising means for administering a substance to a user on the device on the basis of a measured analyte concentration.
61. An device for administering a substance to a user comprising a measuring device for measuring the concentration of an analyte in a bodily fluid from said user, said measuring device comprising a plurality of analyte sensing means and at least one conduit, preferably a microchannel, for conveying said body fluid to at least one of the sensing means; the apparatus further comprising administration means for administering said substance to said user on the basis of said measurement of concentration.
62. A device as claimed in claim 61 wherein the measuring device comprises a self-adhesive patch for attachment to the skin of a user.
63. A device as claimed in claim 61 or 62 wherein said administration means is integrated with the measuring device.
64. An device as claimed in claim 63 wherein the administration means comprises a reservoir on or in the measuring device for dispensing the substance.
65. An device as claimed in claim 64 further comprising a pump for removing said substance from the reservoir.
66. An device as claimed in claim 65 comprising a single pump for both administering said substance to a user's body and for drawing out blood or interstitial fluid, to a sensing means for making an analyte concentration measurement.
67. A device as claimed in any preceding claim comprising electro-osmotic flow control means comprising a plurality of driving electrodes, said driving electrodes being provided substantially on one side of a channel.
68. A device as claimed in claim 67 wherein said driving electrodes extend circumferentially around an arcuate wall of the channel.
69. A device as claimed in any preceding claim comprising a main support member and a second substrate laminated to the main support member, said second substrate layer having one or more electrodes formed thereon.
70. A device as claimed in claim 69 wherein said second substrate is arranged to close a channel provided on the main support member.
71. A device for measuring the concentration of an analyte in a fluid comprising a support member having an open channel on a surface thereof the support member; and a second layer laminated onto said support member so as to close said channel.
72. A device as claimed in claim 71 wherein said channel is a microchannel.
73. A device as claimed in claim 71 or 72 comprising an integrated skin penetration member is provided which is also open on one side.
74. A device as a claimed in claim 73 wherein said skin penetration member is arranged so that upon insertion into skin, the skin itself effectively forms a wall of
75. A device for obtaining fluid through human or animal skin, comprising a skin penetration member having at least one longitudinal side open, the other sides being arranged so as effectively to cause the penetrated skin to act as the remaining longitudinal side of the member when the penetration member is inserted into the skin.
76. Apparatus for measuring an analyte optically comprising a device as claimed in any preceding claim for measuring said analyte and a separate test meter including light sensitive means, wherein said measuring device and said test meter are arranged such that in use the light sensitive means views said analyte along a channel of the measuring device.
77. Apparatus for measuring the light from an assay comprising an elongate conduit portion along which a sample fluid is drawn in use and a light sensitive means arranged to be sensitive to light coming substantially from the longitudinal axis of said conduit portion.
78. A disposable skin patch comprising an elongate conduit portion along which a sample fluid is drawn in use and a moulded plastics lens over said conduit portion.
79. A test meter for use with disposable skin patch as claimed in claim 78 comprising a light sensitive element arranged, in use, to sit over said lens when the meter is placed over the patch.
80. A method of measuring the amount of an analyte in a sample of liquid comprising providing an electrochemical measuring device having a sensor electrode within a microchannel, introducing said sample liquid into said microchannel, and measuring an aggregate current passed by said electrode to give an indication of said amount of analyte in the sample.
81. An electrochemical device for measuring the amount of an analyte in a sample of liquid comprising a sensor electrode disposed within a microchannel and means for measuring an aggregate current passed by said electrode in use to give an indication of said amount of analyte in the sample.
82. A method of making a device for measuring the concentration of a substance in a liquid comprising forming a first channel in a substrate material, fitting said channel at least partially with an electrically conductive material, and forming a second channel so as to intersect said first channel, thereby forming two conductive portions on respective opposite sides of the second channel.
83. A method of fabricating a device for measuring the concentration of an analyte in a fluid comprising providing a support member, forming an open channel on a surface of the support member and laminating a second layer onto said support member so as to close said channel.
84. An apparatus for obtaining and analyzing a sample of a body fluid from a skin layer, said apparatus comprising:
a support member;
a channel formed on said support chamber;
said channel having an entrance for receiving said body fluid;
an analyte sensor carried on said support member and positioned to sense an analyte in said fluid within said channel;
a flow controller for influencing a flow of fluid within said channel to said sensor.
85. An apparatus according to claim 84 further comprising a fluid extraction member for directing fluid from said skin layer to said entrance.
86. An apparatus according to claim 85 further comprising a flow restrictor between said fluid extraction member and said channel.
87. An apparatus according to claim 84 further comprising a waste reservoir in fluid flow communication with said channel.
88. An apparatus according to claim 84 wherein said flow controller includes a flow inhibitor in said channel inhibiting flow of said body fluid into said channel and a reliever for permitting discharge of said inhibitor from said channel to permit said fluid to flow into said channel.
89. An apparatus according to claim 88 wherein said flow inhibitor is an inhibitor fluid in said channel and said reliever includes a switch for permitting selective release of said inhibitor fluid from said channel.
90. An apparatus according to claim 89 wherein said switch includes a membrane blocking passage of said inhibitor fluid from said channel and selectively controllable electrodes for removing said membrane.
91. An apparatus according to claim 90 wherein said membrane is selected to be at least partially destroyed by energization of said electrodes.
92. An apparatus according to claim 89 wherein said inhibitor fluid is air and said switch vents said air from said channel.
93. An apparatus according to claim 84 wherein said flow controller includes a hydrophobic gate.
94. An apparatus according to claim 93 wherein said hydrophobic gate includes a hydrophobic length of said channel.
95. An apparatus according to claim 84 wherein said flow controller includes a bubble disposed in said channel with a vent to said channel to permit selective discharge of said bubble from said channel.
96. An apparatus according to claim 84 wherein said flow controller further comprises a pumping mechanism for urging fluid flow past said flow controller.
97. An apparatus according to claim 96 wherein said pumping mechanism is an electro-osmotic pump.
98. An apparatus according to claim 96 wherein said pumping mechanism is automatically controllable by a controller.
99. An apparatus according to claim 96 wherein said pumping mechanism is selectively controllable by a user.
100. An apparatus according to claim 84 wherein:
said channel is one of a plurality of channels each formed on said support chamber by forming channel defining walls on a said support member and each having an entrance for receiving said body fluid;
said analyte sensor is one of a plurality of analyte sensors each associated with a respective one of said plurality of channels.
101. An apparatus according to claim 100 wherein said controller operates to direct flow into a subsequent one of said plurality of channels after a residence time of said body fluid in a preceding one of said plurality of channels.
102. An apparatus according to claim 100 wherein each of said entrances is connected to a common source of said fluid.
103. An apparatus according to claim 100 wherein said plurality of channels and associated sensors include:
at least a first continuous sensor for sensing a concentration of an analyte in fluid within said channel associated with said continuous sensor; and
at least a first calibration sensor for performing as least one calibration measurement of a concentration of an analyte in fluid within said channel associated with said calibration sensor.
104. A method of continuously sampling and measuring an analyte comprising:
extracting a fluid into a common collection port;
directing said fluid along a channel towards an analyte sensing means;
performing at least an analyte measurement on the fluid;
switching the flow of fluid from one channel to sequentially at least another channel after a certain period of time; and
performing at least a further analyte measurement.
105. An apparatus according to claim 84 further comprising an administrator for administering a substance to a user based upon a measuring based upon a sensing of said analyte sensor.
106. An apparatus for obtaining and analyzing a sample of a body fluid from a skin layer, said apparatus comprising:
a support member;
a channel formed on said support chamber by forming channel defining wall on a said support member;
said channel having an entrance for receiving said body fluid;
said channel having a minute size with a volume less than 200 nanoliters;
an analyte sensor carried on said support member and positioned to sense an analyte in said fluid within said channel.
107. An apparatus according to claim 106 wherein said channel has a longitudinal dimension less than 10 mm.
108. An apparatus according to claim 106 wherein said channel has a lateral dimension less than 200 micrometres.
109. An apparatus according to claim 108 wherein said lateral dimension is greater than 10 micrometres.
110. An apparatus according to claim 106 wherein said analyte sensor includes a reagent deposited on said wall for reacting with an analyte of said fluid when said fluid is within said channel.
111. An apparatus according to claim 106 further comprising a fluid extraction member for directing fluid from said skin layer to said entrance.
112. An apparatus according to claim 111 wherein said fluid extraction member is a penetration member for penetrating into only a cutaneous layer of said skin layer and said fluid extraction member has a fluid pathway for fluid to flow from said cutaneous layer to said entrance of said channel.
113. An apparatus according to claim 112 comprising a plurality of said fluid extraction members.
114. An apparatus according to claim 112 wherein said penetration member is a hollow needle with a bore of said needle defining said fluid pathway.
115. An apparatus according to claim 112 wherein said penetration member is a lance having opposing surfaces defining said fluid pathway and with said fluid pathway open to an exterior of said lance.
116. An apparatus according to claim 111 wherein said fluid extraction member includes means for iontophoretic transfer of fluid from said skin layer to said entrance.
117. An apparatus according to claim 111 wherein said fluid extraction member includes means for ultra-sonic transfer of fluid from said skin layer to said entrance.
118. An apparatus according to claim 111 wherein said fluid extraction member includes means for suction-assisted transfer of fluid from said skin layer to said entrance.
119. An apparatus according to claim 111 further comprising an electric field generator for stimulating the skin layer and urging fluid to flow to said entrance.
120. An apparatus according to claim 119 wherein said fluid extraction member includes an electrode which comprises a portion of said electric field generator.
121. An apparatus according to claim 86 further comprising a flow controller for influencing a flow of fluid within said channel to said sensor.
122. An apparatus according to claim 86 wherein:
said channel is one of a plurality of channels each formed on said support chamber by forming channel defining walls on a said support member and each having an entrance for receiving said body fluid;
said analyte sensor is one of a plurality of analyte sensors each associated with a respective one of said plurality of channels.
123. An apparatus according to claim 101 wherein each of said entrances is connected to a common source of said fluid.
124. An apparatus according to claim 101 wherein said plurality of channels and associated sensors include:
at least a first continuous sensor for sensing a concentration of an analyte in fluid within said channel associated with said continuous sensor; and
at least a first calibration sensor for performing as least one calibration measurement of a concentration of an analyte in fluid within said channel associated with said calibration sensor.
125. An apparatus according to claim 106 wherein said analyte sensor includes an electro-chemical sensor.
126. An apparatus according to claim 106 wherein said analyte sensor includes a plurality of electrodes.
127. An apparatus according to claim 106 wherein at least one of said electrodes is an electrically conductive material deposited in said channel.
128. An apparatus according to claim 106 wherein said channel is formed in an electrically conductive material with said material comprising at least one of said electrodes.
129. An apparatus according to claim 106 wherein said analyte sensor includes a calorimetric sensor.
130. An apparatus according to claim 106 further comprising an administrator for administering a substance to a user based upon a measuring based upon a sensing of said analyte sensor.
131. An apparatus for obtaining and analyzing a sample of a body fluid from a skin layer, said apparatus comprising:
a support member;
a channel formed on said support chamber by forming channel defining wall on a said support member;
said channel having an entrance for receiving said body fluid;
said channel having a reagent deposited on said wall for reacting with an analyte of said fluid when said fluid is within said channel.
132. An apparatus according to claim 131 wherein said channel has a volume less than 200 nanoliters.
133. An apparatus according to claim 132 wherein said channel has a longitudinal dimension less than 10 mm.
134. An apparatus according to claim 132 wherein said channel has a lateral dimension less than 500 micrometres.
135. An apparatus according to claim 134 wherein said lateral dimension is less than 200 micrometres.
136. An apparatus according to claim 135 wherein said lateral dimension is greater than 10 micrometres
137. An apparatus according to claim 131 further comprising a fluid extraction member for directing fluid from said skin layer to said entrance.
138. An apparatus according to claim 137 wherein said fluid extraction member is a penetration member for penetrating into only a cutaneous layer of said skin layer and said fluid extraction member has a fluid pathway for fluid to flow from said cutaneous layer to said entrance of said channel.
139. An apparatus according to claim 138 wherein said penetration member is a hollow needle with a bore of said needle defining said fluid pathway.
140. An apparatus according to claim 138 wherein said penetration member is a lance having opposing surfaces defining said fluid pathway and with said fluid pathway open to an exterior of said lance.
141. An apparatus according to claim 131 further comprising a flow controller for influencing a flow of fluid within said channel to a portion of said channel containing said reagent.
142. An apparatus according to claim 131 wherein:
said channel is one of a plurality of channels each formed on said support chamber by forming channel defining walls on a said support member and each having an entrance for receiving said body fluid;
each of said channels provided with a respective reagent on a defining wall of said channels.
143. An apparatus according to claim 142 wherein each of said entrances is connected to a common source of said fluid.
144. An apparatus according to claim 142 wherein said plurality of channels includes:
at least a first continuous sensor for sensing a concentration of an analyte in fluid within said channel associated with said continuous sensor; and
at least a first calibration sensor for performing as least one calibration measurement of a concentration of an analyte in fluid within said channel associated with said calibration sensor.
145. An apparatus for obtaining and analyzing a sample of a body fluid from a skin layer, said apparatus comprising:
a support member;
a channel formed on said support chamber by forming channel defining wall on a said support member;
said channel having an entrance for receiving said body fluid;
a fluid extraction member for directing fluid from said skin layer to said entrance;
said channel having a minute size with a volume less than 200 nanoliters;
an analyte sensor carried on said support member and positioned to sense an analyte in said fluid within said channel.
146. An apparatus according to claim 145 wherein said channel has a longitudinal dimension less than 10 mm.
147. An apparatus according to claim 145 wherein said channel has a lateral dimension is less than 200 micrometres.
148. An apparatus according to claim 147 wherein said lateral dimension is greater than 10 micrometres.
149. An apparatus according to claim 145 wherein said analyte sensor includes an electrochemical sensor positioned to be in contact with said fluid when said fluid is within said channel.
150. An apparatus according to claim 145 wherein said fluid extraction member is a penetration member for penetrating into only a cutaneous layer of said skin layer and said fluid extraction member has a fluid pathway for fluid to flow from said cutaneous layer to said entrance of said channel.
151. An apparatus according to claim 150 wherein said penetration member is a hollow needle with a bore of said needle defining said fluid pathway.
152. An apparatus according to claim 150 wherein said penetration member is a lance having opposing surfaces defining said fluid pathway and with said fluid pathway open to an exterior of said lance.
153. An apparatus according to claim 145 further comprising a flow controller for influencing a flow of fluid within said channel to said sensor.
154. An apparatus according to claim 145 wherein:
said channel is one of a plurality of channels each formed on said support chamber by forming channel defining walls on a said support member and each having an entrance for receiving said body fluid;
said analyte sensor is one of a plurality of analyte sensors each associated with a respective one of said plurality of channels.
155. An apparatus according to claim 154 wherein each of said entrances is connected to a common source of said fluid.
156. An apparatus according to claim 154 wherein said plurality of channels and associated sensors include:
at least a first continuous sensor for sensing a concentration of an analyte in fluid within said channel associated with said continuous sensor; and
at least a first calibration sensor for performing as least one calibration measurement of a concentration of an analyte in fluid within said channel associated with said calibration sensor.
157. An apparatus according to claim 84 further comprising an administrator for administering a substance to a user based upon a measuring based upon a sensing of said analyte sensor.
158. An apparatus according to claim 84 wherein said analyte sensor includes a light sensor disposed to be sensitive to light coming substantially from a longitudinal axis of said channel.
159. An apparatus for obtaining and analyzing a sample of a body fluid from a skin layer, said apparatus comprising:
a support member;
a plurality of channels each formed on said support chamber by forming channel defining walls on a said support member;
each of said channels having an entrance for receiving said body fluid;
a plurality of analyte sensors each associated with a respective one of said plurality of channels, each of said analyte sensors carried on said support member and positioned to sense an analyte in said fluid within said respective one of said plurality of channels.
160. An apparatus according to claim 159 wherein said channel has a minute size with a lateral dimension less than 500 micrometres.
161. An apparatus according to claim 159 wherein said channel has a volume less than 200 nanoliters.
162. An apparatus according to claim 161 wherein said channel has a longitudinal dimension less than 10 mm.
163. An apparatus according to claim 160 wherein said lateral dimension is less than 200 micrometres.
164. An apparatus according to claim 163 wherein said lateral dimension is greater than 10 micrometres
165. An apparatus according to claim 159 wherein said analyte sensor includes an electrochemical sensor positioned to be in contact with said fluid when said fluid is within said channel.
166. An apparatus according to claim 159 further comprising a fluid extraction member for directing fluid from said skin layer to said entrance.
167. An apparatus according to claim 166 wherein said fluid extraction member is a penetration member for penetrating into only a cutaneous layer of said skin layer and said fluid extraction member has a fluid pathway for fluid to flow from said cutaneous layer to said entrance of said channel.
168. An apparatus according to claim 167 wherein said penetration member is a hollow needle with a bore of said needle defining said fluid pathway.
169. An apparatus according to claim 167 wherein said penetration member is a lance having opposing surfaces defining said fluid pathway and with said fluid pathway open to an exterior of said lance.
170. An apparatus according to claim 159 wherein each of said entrances is connected to a common source of said fluid.
171. An apparatus according to claim 159 wherein said plurality of channels and associated sensors include:
at least a first continuous sensor for sensing a concentration of an analyte in fluid within said channel associated with said continuous sensor; and
at least a first calibration sensor for performing as least one calibration measurement of a concentration of an analyte in fluid within said channel associated with said calibration sensor.
172. An apparatus according to claim 159 further comprising an administrator for administering a substance to a user based upon a measuring based upon a sensing of said analyte sensors.
173. A method of making a device for measuring the concentration of a substance in a liquid, said method comprising:
forming a first channel in a substrate material;
fitting said channel at least partially with an electrically conductive material;
forming a second channel so as to intersect with said first channel.
174. A method of fabricating a device for measuring the concentration of an analyte in a fluid, said method comprising:
forming a support member;
forming an open channel on a surface of the support member;
laminating a layer onto said support member so as to close said channel.
175. An apparatus according to claim 174 wherein said laminate layer contains electrodes disposed to be in contact with said open channel.
176. An apparatus according to claim 175 wherein said electrodes are formed through a screen-printing process.
Description
    I. BACKGROUND OF THE INVENTION
  • [0001]
    This invention relates to apparatus for and methods of measuring certain properties of a fluid particularly although not exclusively, bodily fluids and the concentrations of certain analytes therein. At least some aspects of the invention relate particularly to the measurement of glucose levels in blood and other body fluids such as cutaneous (interstitial) and sub-cutaneous fluid.
  • [0002]
    Over recent years there have been two obvious trends in diagnostic device development: simplification of the test procedure and reduction in the volume of sample required to perform the test. Test simplification allows the assay to be performed by relatively untrained personnel in a “non-laboratory” setting. Thus, for example, cardiac marker tests configured in a lateral flow immunoassay format with labelled antibody allow for early assessment of potential myocardial infarct.
  • [0003]
    The driving force for the development of tests requiring smaller sample volumes is the reduction of discomfort of the patient. This is particularly important in home tests where, for example, if a glucose test is less painful the user will test more frequently. It is now well documented that diabetics who monitor their blood sugar frequently achieve better glycaemic control and so avoid long-term complications of the disease. With this thought in mind, a number of companies have developed test devices requiring progressively smaller sample volumes, thereby minimising pain.
  • [0004]
    Some proposals have been made to attempt to reduce the amount of pain involved by with so-called minimally invasive devices (e.g. Integ U.S. Pat. Nos. 5,746,217; 5,820,570; and 5,582,184). Unfortunately, such devices appear to be unable to provide sufficient fluid sample to provide a reliable result and thus, as yet, none has been commercially realised.
  • [0005]
    In the context of glucose measurement, so-called continuous monitors are also known and these have certain advantages over the ‘snapshot’ devices outlined above since they provide a clearer insight into trending, the effect of food or medication and overall glycaemic control. Such known devices however suffer from a number of drawbacks, mainly associated with the need to recalibrate the device regularly. This entails performing regular manual tests using a conventional test strip. This can negate many of the advantages of using a continuous device since the user is still relied upon to take action in order for the device to operate properly. Furthermore the accuracy of the devices tends to drift unpredictably between calibrations. The regular finger pricks are also painful. Examples of continuous monitoring sensors include International patent application PCT/DE99/03126 (International Publication WO 00/22977 published 27 Apr. 2000) and International patent application PCT/US99/16378 (International Publication WO 00/04832 published 3 Feb. 2000).
  • II. SUMMARY AND OBJECTS OF THE INVENTION
  • [0006]
    It is an object of the invention to provide an improved arrangement and when viewed from a first aspect the invention provides a device for measuring the concentration of an analyte in a fluid, comprising a support member, analyte sensing means provided thereon for measuring said concentration and a microchannel in fluid communication with said analyte sensing means for conveying said fluid to said sensing means.
  • [0007]
    Thus it will be seen that in accordance with the invention a microchannel is used to convey the sample fluid to the sensing means.
  • [0008]
    As used herein the term “microchannel” refers to a channel, of any suitable cross-section, whose lateral dimension is between approximately 10-500 μm.
  • [0009]
    Such microchannels are beneficial for a number of reasons in the context of an analyte sensing device. In the context of the measurement of a bodily fluid a small sample volume is beneficial since it means that it is easier to provide a sufficient volume for a valid test. Most importantly the volume of fluid required to carry out an assay is correspondingly small, in addition the microchannel allows to handle flow rates between 10 and 500 nL/min with a high resolution of the measurement over time, due to the low channel volume. The analyte sensing means can be arranged in any suitable configuration depending on the type of sensing means used (electrochemical, optochemical etc.). Preferably the analyte sensing means comprises one or more reagents to react with said analyte and thereby give a measurable output. Such a reagent may be located anywhere, but preferably the reagent or at least one of the reagents is provided on a wall of the microchannel. This arrangement is beneficial since it means that no additional volume is required in order for the sample liquid to be brought fully into contact with the reagent—i.e. the contact area is optimised. When viewed from a second aspect the invention provides a device for measuring the concentration of an analyte in a fluid, comprising a support member and a microchannel provided on said support member for conveying said fluid across the support member, wherein one or more reagents for reacting with said analyte is coated on a wall of the microchannel.
  • [0010]
    Preferably such a device further comprises means for sensing the analyte—for example an electrochemical or a photometric detector.
  • [0011]
    The devices set out hereinabove may be used for measuring any suitable analyte in any suitable fluid. However the invention, in its various aspects, finds particularly beneficial application in the measurement of analytes in human or animal bodily fluids. Of course, a suitable sample of bodily fluid may be applied to the device. Preferably however the device is integrated with means for extracting the fluid. Most preferably this comprises means for penetrating the skin—in the case where the sample fluid is blood or interstitial fluid. Most preferably it comprises a skin penetration member such as hollow needle, solid lance or the like.
  • [0012]
    In accordance with the embodiments set out above the device can be used both to collect the sample fluid and to measure the concentration of the target analyte—or at least give an output from which the concentration can be measured. When viewed from a further aspect the present invention provides a device for measuring the concentration of an analyte in a fluid, comprising a support member, means provided on the support member for sensing said analyte, wherein said support member further comprises fluid extraction means arranged to direct fluid to said analyte sensing means via a conduit on the support member.
  • [0013]
    Thus it will be seen that in accordance with this aspect of the invention a fluid extraction means, preferably a skin penetration means, most preferably a needle, lance or the like, is provided on a support member of a device for measuring analyte concentration. This allows, in at least preferred embodiments, the combination of skin penetration means, e.g. needle, and support member, e.g. test strip, to be made disposable and thus as hygienic as possible. The preferred embodiments require a user merely to puncture their skin with a needle or the like and then blood or interstitial fluid may be conducted automatically onto or into the test member. Devices for extracting interstitial fluid are shown in the afore-mentioned Integ patents and International patent application PCT/US01/09673 (International Publication WO 01/72220 published 4 Oct. 2001).
  • [0014]
    In such embodiments the combined needle/test member would normally be used in conjunction with a separate, non-disposable, measuring device for measuring the analyte concentration e.g. by means of the output of an analyte-reagent reaction, where appropriate.
  • [0015]
    The dimensions of the needle, lance or the like may be suited to the particular application. In fact, any mechanism for extracting interstitial fluid may be used with the present invention. While the present invention will be described with reference to a shallow penetration needle, the invention is application to any technique for obtaining a body fluid.
  • [0016]
    For example a standard hypodermic needle several centimetres in length may be employed. Whilst the device may be used to sample interstitial fluid or blood from the cutaneous and/or the subcutaneous layers, in preferred embodiments however, the penetration member is of such a length that it penetrates substantially the cutaneous layer of skin. When the term “substantially the cutaneous layer” is referred to, it means that whilst it is the intention to sample fluid from the cutaneous layer, it cannot be ruled out that some sampling from the sub-cutaneous may occur. The cutaneous layer has a high density of blood capillaries which helps to ensure that the levels of analytes in interstitial fluid reliably reflect those in the blood.
  • [0017]
    While not limited to analysing interstitial fluid (ISF), the present invention is preferably used in obtaining and analysing ISF. A further benefit offered by interstitial fluid is that it is not as complex as whole blood and therefore does not, for example, suffer from Haematocrit fluctuations. ISF also has a low viscosity and is more suited to passage through microchannels than whole blood. The low sample volume requirement of a microchannel also enables the device reliably to use interstitial fluid.
  • [0018]
    Perhaps more improtantly such shallow skin penetration (cutaneous or subcutaneous) substantially reduces the pain experienced since there is a much lower density of nerve endings than at the depths penetrated by standard needles when extracting blood. Indeed, in at least preferred embodiments, little or no pain is normally felt. This makes prolonged and/or repeated penetration of the skin much more acceptable.
  • [0019]
    The actual length of the penetration means will depend on the angle at which it is intended to be inserted. Thus if shallow angle penetration is intended, the length may by of the order of several millimetres e.g. up to approximately 7 to 10 millimetres. Preferably however substantially perpendicular insertion is intended and the length is less than 2 mm, preferably less than 1.5 mm. In some preferred embodiments a length of approximately 1.4 mm is appropriate. However for certain applications a length as short as 0.5 mm may be preferred
  • [0020]
    Of course a given test member may have just one skin penetration member, or alternatively a plurality may be provided.
  • [0021]
    The penetration means may comprise a sufficiently short standard needle, possibly shortened if necessary. More preferably the penetration means comprises a microneedle. A microneedle is hereby defined as a needle with a length sufficient to penetrate the cutaneous layer of human skin without substantially penetrating the subcutaneous layer. Such a needle typically has length less than 2 mm, preferably between 0.4 and 1.6 mm.
  • [0022]
    The outer diameter is preferably less than 0.5 mm, most preferably between 0.1 and 0.3 mm.
  • [0023]
    The penetration means need not be integrated with the support member, but preferably is. The comments above regarding this arrangement apply, with the additional benefit noted here that preferred embodiments of this arrangement can provide a compact disposable device which gives rise to substantially no pain, in use and obviates the need for a user to come into contact with or even see the bodily fluid concerned.
  • [0024]
    In a particularly preferred embodiment the analyte is glucose.
  • [0025]
    Preferred embodiments of the invention use a reagent-based measurement. Many different reagent-based analyte measurements are available to those skilled in the art, allowing the principles of the invention to find wide application. For example an optochemical—i.e. either fluorescent or luminescent—or an electrochemical technique could be used.
  • [0026]
    One preferred embodiment comprises analyte sensing means comprising a mediated amperometric enzyme electrode. For example, a ferrocene-mediated electron transfer from a glucose-oxidase catalysed reaction is a suitable means for detecting the level of glucose in a body fluid. Other enzymes, such as lactate oxidase or lactate dehydrogenase and cholesterol oxidase dehydrogenase may be used to measure lactate and cholesterol levels respectively. It will be appreciated that use of the above electron-transfer mediator is a non-limiting example and that other electron transfer mediators well known in the art could be used, for example, hexa-cyanoferrate (ferricyanide), oxygen or components of the respiratory chain (i.e. cytochromes).
  • [0027]
    Preferably the embodiment will comprise an analyte sensing means which operates in conjunction with a test meter to give the measurement. Alternatively the member may comprise the appropriate reagent or dye for performing a calorimetric test in association with light sensitive means in the test meter. It will be seen that such arrangements are consistent with the test device being disposable since the costly elements of the sensing mechanism, such as the light sensitive means, electronic circuity etc., can be placed in a non-disposable test meter.
  • [0028]
    Just single analyte sensing means may be provided, but preferably more than one is provided.
  • [0029]
    Thus it will be seen that in accordance with this aspect of the invention, a plurality of conduits direct fluid to be measured to respective analyte sensing means. This means that a plurality of measurements of fluid may be made by a single such device. The sensing means may be different so as to measure or test for different analytes in the fluid. Preferably however they are the same or at least are for measuring the same analyte. When viewed from a further aspect the invention provides a device for measuring the concentration of an analyte in a fluid, comprising a support member and a plurality of analyte sensing means provided thereon for measuring said concentration, wherein said device further comprises a plurality of conduits such that each of said sensing means has a conduit associated therewith, said conduits serving in use to direct said fluid to respective sensing means. The device, whether it comprises a single or a plurality of conduit/analyte sensors, may be used to continuously measure the concentration of the analyte over a period of time. Periodic measurements may be taken i.e. the fluid is “sampled” at various periods over time, for example every 30 minutes. Fluid may continuously flow through the device or may be temporarily stopped by, for example, hydrophobic gates. As yet another alternative, the sensors may be of the single measurement type, after which the device is discarded or fluid is diverted to another conduit to perform another measurement. The total time taken to complete a measurement cycle or the time taken between measurements could vary and would depend upon the degree of monitoring or the analyte of interest. The plurality of conduits would allow for switching from sensor to another after a particular period of time, by diverting fluid flow from one conduit to another. Switching enables measurements to be performed without interruption to the fluid extraction or without having to recalibrate the sensors, which are known to drift after a period of time due to factors such as electrode fouling etc.
  • [0030]
    Thus analyte monitoring may be made on a truly continuous basis, without the user having to recalibrate or interact with the system. An advantage of performing a single measurement, either in the case of a device with a single or plurality of microchannels is that drifting of the signal over time is no longer an issue that has to be considered and consequently simpler reagent chemistries may be employed in the analyte sensors. For example in the case of an electrochemical detection system, results may be obtained in as little as five seconds or less. Furthermore, such devices would not require storage reservoirs for collection of the waste fluid, since the waste fluid would be stored in the microchannel conduits themselves.
  • [0031]
    In principle, there would be no upper limit to the number of sensor/conduits contained within a device, the upper limit being determined by factors such as the desired total length of time for analyte measurement or by the size of the device.
  • [0032]
    Whilst the above embodiments describe a flow-through sensor, i.e. the analyte is measured whilst flowing past the detection means, measurements may also be conducted whilst the fluid is stationary. This could be achieved by the use of flow controlling means such as a hydrophobic gate or gates being activated to temporarily stop the flow of fluid through the microchannel once it had passed the sensing means. Isolating or shutting off a volume of fluid from the rest of the fluid sample would enable an end-point determination of the total amount of analyte present in the particular portion of the sample to be made.
  • [0033]
    As described above, the sensing means may be electrochemical or non-electrochemical in nature—e.g. of the fluorescent or chemi-luminescent calorimetric sort. For example the sensing means may comprises an enzyme-coated electrode in the case of electrochemical measurement, or in the case of fluorescent colorimetric sensing the sensing means would comprise a suitable reagent dye. It will, of course, be understood that the term ‘sensing means’ does not necessarily refer to a complete assembly for giving a final reading, but rather to a means on the support member which yields an output which may be read to give a measure of the analyte concentration, e.g. by a separate test meter.
  • [0034]
    Such devices according to embodiments of the invention as set out above could be arranged to be used in a mode similar to conventional test strips i.e. where a single fluid sample is placed on the device and is measured.
  • [0035]
    In common with earlier aspects of the invention, devices of the sort set out above may be arranged to measure the concentration of any suitable analyte. In all such cases, the analyte's concentration may simply be an indirect indication of the property of the sample fluid which it is desired to monitor. For example a detection reagent (e.g. an enzyme substrate or an antigen) may be added to the sample so as to bind selectively and/or react with certain proteins in the fluid such as enzymes or antibodies. In this case the added detection reagent or the product of the enzyme-catalysed reaction, comprises the analyte. Devices in accordance with the invention can therefore be arranged to measure such analytes—i.e. it will be seen that such devices may be used to measure the activity of enzymes in a body fluid sample, or test whether antibodies to a particular antigen are present in the body fluid.
  • [0036]
    Preferably however, the device is arranged to measure an analyte concentration directly—i.e. it is the concentration itself which is being monitored. An example of such a measurement would be glucose in blood, the concentration of which is an important parameter for those suffering from diabetes.
  • [0037]
    In a particularly preferred embodiment the measuring device is suitable for measuring the concentration of an analyte, e.g. glucose, in blood or interstitial fluid. In such an embodiment the device is preferably suitable for attachment to the skin of the subject who is to be measured. The subject may be an animal but,is preferably human.
  • [0038]
    By providing a device which can be attached to a subject, measurements of the concentration of the substance in the subject's blood or interstitial fluid can be carried out repeatedly over a period of time.
  • [0039]
    This means that inconvenience and discomfort to the user is significantly reduced and moreover that tests can be carried out at regular intervals and at a greater frequency than would otherwise be tolerable. The result of this in the preferred application of the invention to blood glucose monitoring is that an improved insight into glycaemic control and the effects of food, medication and general trends on the glucose level is given. Moreover, by attaching the device to the patient and therefore making the device portable, it allows the patient to lead as normal life as possible. It also allows for the possibility of continuous measurements during periods when it may not be convenient to self-monitor by conventional manual methods of testing, for example during prolonged periods of exercise or whilst sleeping. The device could therefore include an alarm or means to activate an alarm in order to alert or wake the patient or any third party in case of a particular analyte level, for example in the case of hypoglycaemia.
  • [0040]
    Accordingly it is preferred that the devices comprise a penetration member with a sufficiently length substantially to penetrate the cutaneous layer of skin, most preferably integrally formed with the support member. It is further preferred that such devices comprises at least one microchannel for conveying the interstitial fluid to one or more of the sensing means.
  • [0041]
    When viewed from a further aspect the present invention provides a device for measuring the concentration of a given analyte in a bodily fluid comprising means for attaching the device to the skin of a subject and a plurality of sensing means for making a plurality of measurements of said concentration over a period of time.
  • [0042]
    It will be seen that effectively this aspect of the invention provides a device which can perform a plurality of measurements in situ, that is without user intervention being required. This has clear benefits in removing some constraints on the number, frequency and regularity with which measurements can be performed. Each sensing element in the device is designed to be used for a certain predetermined time during which the signal will not significantly drift over time. In this sense “significantly” represents the amount of drift permitted such the measurement result would not be affected by an clinically unacceptable amount. After such a period fluid is then switched to a new sensor and the process repeated. Preferably the device is provided with flow control means for influencing the flow of fluid to the sensing means. Any suitable flow control method may be employed with corresponding means to affect such a control method. For example Piezo-electric pumping, electrokinetic or mechanical methods such as ‘unblocking’ the flow along a selected conduit.—e.g. by allowing a gas bubble to escape or by opening a valve.
  • [0043]
    In certain embodiments the flow control means comprises a hydrophobic gate situated within the conduit/microchannel. A hydrophobic gate as herein disclosed refers to a hydrophobic surface region within a hydrophilic channel such that the flow of fluid is interrupted. By changing the hydrophobic nature of the gate, i.e. by making the hydrophobic region more hydrophilic, fluid may then be allowed to flow along the channel. Hydrophobic gates may be used to control the flow of fluid within a single microchannel or may be used to switch or redirect flow from one microchannel to another.
  • [0044]
    Alternatively, the hydrophobic nature of the gate may be maintained as it is and a increased pumping force (e.g. provided by a mechanical or electro-osmotic pump) may be applied in order for the fluid to breach the hydrophobic gate.
  • [0045]
    Preferably the device is arranged to direct fluid sequentially to each of the sensing means. The timing of the direction of the fluid to the sensing means could be pre-configured for example by software within the meter, such that the fluid is switched after a predetermined period of time. Preferably however the device comprises, or is adapted to interface with, control means to control said direction of the fluid to the sensing means. Such control is preferably automatic.
  • [0046]
    Additionally or alternatively however the control means may be such as to allow a user to specify when a measurement is to be made. This is beneficial as it allows measurement on demand which is useful for example in the case of blood glucose monitoring, as it allows the user to determine the effect on blood glucose of eating a particular snack or to determine how much insulin it is necessary to inject prior to eating or the user may simply want to carry out a check for reassurance. This enables the device to make periodic measurements of fluid from the body of the subject using fresh fluid for each measurement, thereby facilitating the desired object of monitoring the concentration of the substance in question over a period of time.
  • [0047]
    Where, as is preferred, each microchannel or other conduit is associated with a respective flow control means, each may be individually addressable by a suitable control means. This gives significant flexibility in how such a device may be used.
  • [0048]
    Preferably the device comprises a common fluid collection region in fluid communication with the bodily fluid to be measured—e.g. via a needle—each sensing means preferably being in selective fluid communication with said common collection region. Thus when viewed from a further aspect the present invention provides a device for making a plurality of measurements of the concentration of an analyte in a fluid comprising a common sample collection site in fluid communication with the fluid to be measured and a plurality of sensing means for measuring said concentration.
  • [0049]
    Where not otherwise specified, any suitable conduit may be provided for conveying the fluid to be measured to the sensing means, but preferred arrangements comprise microchannels as defined herein. Furthermore in the context of a plurality of analyte sensing means, the provision of microchannels allows many test elements to be positioned in close proximity thereby enabling even devices comprising a large number of sensing means to be made relatively small. This is beneficial in applications where the size and weight of the device is an important consideration, such as when it is attached to the user's body.
  • [0050]
    As well as the understood benefits per se of a low sample volume arising from the use of microchannels, the Applicants have realised that such a small sample volume makes it practicable to change the mode of testing. More particularly it has been realised that a very low sample volume means that rather than conduct the usual reaction rate measurement as in known electrochemical devices e.g. for detecting blood analytes such as glucose, where electron transfer is measured as a function of time to determine the rate of transfer, an end-point test can be carried out in which the total amount of analyte in the sample volume is measured, thereby consuming substantially all of the analyte.
  • [0051]
    It has been appreciated that this is advantageous over rate measurements since the latter tend to be prone to interference, temperature and Haematocrit fluctuations (in the case of using blood). Whereas such a measurement method would take a prohibitively long time with known measuring devices, by using microchannels in accordance with the invention to give a required sample volume of the order of a few nano-litres, such a measurement can typically be completed in the order of a few seconds, thereby making it a practical proposition.
  • [0052]
    When viewed from a yet further aspect the present invention provides a method of measuring the amount of an analyte in a sample of liquid comprising providing an electrochemical measuring device having a sensor electrode within a microchannel, introducing said sample liquid into said microchannel, and measuring an aggregate current passed by said electrode to give an indication of said amount of analyte in the sample.
  • [0053]
    This aspect of the invention also extends to an electrochemical device for measuring the amount of an analyte in a sample of liquid comprising a sensor electrode dispos d within a microchannel and means for measuring an aggregate current passed by said electrode in use to give an indication of said amount of analyte in the sample.
  • [0054]
    The invention also extends to an equivalent arrangement using a non-electrochemical sensing means—e.g. a calorimetric one.
  • [0055]
    Any suitable transfer means for transferring the fluid from the user's body to the device may be employed. Preferably methods such as suction, ultra-sound or iontophoresis may be used. More preferably however the transfer means comprises a needle. In particularly preferred embodiments the needle is a microneedle as defined hereinabove.
  • [0056]
    The needle is preferably shaped to aid skin penetration. For example the tip region of the needle is preferably substantially conical. Furthermore it is preferred that the tip region has a reduced cross-section—preferably less than 0.2 mm in width, most preferably less than 0.05 mm in width.
  • [0057]
    Moreover the needle is preferably arranged to minimise the risk of blockage upon insertion into skin. For example the aperture of the needle may be provided on a side surface of the needle, rather than at the tip as is conventional. Preferably the aperture of the needle is recessed, thereby avoiding contact with the skin upon penetration and thus potential blocking and/or damage
  • [0058]
    The needle preferably has a bore such that the sample fluid is drawn up by capillary action. Suitable needle bore sizes range preferably from 21-30 most preferably 25. Any suitable inert and biocompatible material for the needle may be employed.
  • [0059]
    Examples of such inert materials include but are not limited to stainless steel, gold, platinum and metal-coated plastics
  • [0060]
    Most preferably one or more microneedles is employed as defined hereinabove.
  • [0061]
    The methods above may be supplemented by applying pressure to the user's skin around the site at which it is penetrated. Such pressure could be applied purely manually, but preferably the device comprises means—e.g. suitably configured resilient means—to apply the pressure. The device may have skin pressurising means as explained in more detail below and as shown in the figures. Examples of skin pressurising means are set out in copending application US09/877,514 filed Jun. 8, 2001.
  • [0062]
    Preferably therefore the devices of the preferred embodiments comprise display means to display the concentration of the analyte being measured such as blood glucose. Such display means may be coupled directly to the measuring device, but preferably it is separate from the device and receives data therefrom by telemetry. This approach has the advantage that the measuring device can be very light and thus comfortable to wear. For example the measuring device may be worn under clothing but monitored on a display means kept, say, in a pocket or for example in the form of a watch worn on the arm of the user, without the user having to disturb their clothing in order to view it.
  • [0063]
    Additionally or alternatively the device comprises or is coupled to means for administering a substance to a user on the device on the basis of the measured concentration. Thus in the previous example of a blood glucose monitoring device, rather than just being a passive monitoring device, undoubtedly useful per se, such a device can be used in conjunction with an insulin pump to maintain the user's glucose level within a desired range.
  • [0064]
    The insulin pump could be a separate device or alternatively could be integrated within the analyte sensing device per se. Controlling means present for example within the meter could control the amount of insulin administered by the insulin pump in response to the level of glucose measured by the device.
  • [0065]
    By effectively providing a feedback loop, preferred embodiments of this inventive feature can allow a diabetic, to maintain control of his/her glucose levels with a minimum of intervention i.e. only to replace consumable items such as a sensor/insulin patch.
  • [0066]
    Furthermore, particularly where a continuous sensing means is employed, tighter control of, say glucose level, is achievable than where intermittent manual tests and insulin administration are used.
  • [0067]
    Thus when viewed from a yet further aspect the present invention provides an apparatus for administering a substance to a user comprising a measuring device for measuring the concentration of an analyte in a bodily fluid from said user, said measuring device comprising a plurality of analyte sensing means and at least one conduit, preferably a microchannel, for conveying said bodily fluid to at least one of the sensing means; the apparatus further comprising means to administer said substance to said user on the basis of said measurement of concentration.
  • [0068]
    In accordance with all appropriate aspects of the invention, the measuring device preferably comprises a means for attachment to the skin of a user, for example in the form of a self-adhesive patch. This can provide a secure but comfortable arrangement for use over prolonged periods of time, and can be relatively unobtrusive.
  • [0069]
    The means for administering the substance may be entirely separate from the measuring device or integrated therewith. Preferably such an integrated administering means comprises a reservoir on or in the measuring device for dispensing the substance. In a particular embodiment the substance, such as insulin, is contained within a reservoir on an adhesive patch. The actual means for getting the substance from such a reservoir could comprises anything suitable such as a pressurised supply in conjunction with a flow control means such as a valve. Preferably however a pump is used. In a preferred embodiment a single pump may be used both to administer the substance, such as insulin, to a user's body and also to draw out blood or preferably interstitial fluid, to a sensing means for making an analyte concentration measurement e.g. of glucose.
  • [0070]
    Thus, for example, a suitable device may comprise an adhesive patch comprising a microneedle (as defined herein) coupled to or in fluid communication with an array of microchannels and a separate needle for injecting insulin. In a preferred embodiment a single pump, e.g. a silicon micro-pump, may be used to inject insulin from a reservoir on the patch and to draw interstitial fluid over a glucose sensing means to a waste reservoir.
  • [0071]
    Where an embodiment of the invention calls for control and/or data processing means, these will generally comprise electronic means such as an integrated circuit or the like. A power supply is then also required. Preferably such control/processing means are portable. It or they may be provided in an integral package with the device e.g. the adhesive patch. Alternatively the control/processing means and/or power source may be provided separately and communicate with measuring device via a wire or wireless telemetry link as mentioned above.
  • [0072]
    The power source may be a battery or may be a ‘renewable’ source such as a solar cell or a dynamo energised by movement of the user. Of course a combination of these could be employed.
  • [0073]
    Measuring devices in accordance with the present invention may be fabricated using any suitable technique. In particular, where provided, the microchannels may be made using any suitable micro-fabrication technique such as but not limited to embossing, plasma etching or injection moulding
  • [0074]
    In one preferred embodiment, electrodes are provided on opposing sides of a fluid channel by forming a first channel which is filled with a conductive material, and forming a second channel for conveying the test fluid, the second channel cutting across the first thereby thereby forming two conductive portions within respective opposite sides of the second channel.
  • [0075]
    The conductive portions formed in accordance with the invention could be utilised for an electrochemical sensor arrangement. Micromachining techniques for making the abovementioned intersecting channels are preferred since they can be used to fabricate microchannels which can be formed close to one another, permitting dense arrays thereof. Furthermore, where the device has flow control means operating via electro-osmotic force, the driving electrodes are preferably positioned in close proximity to one another. This allows high electric fields to be achieved without applying unnecessarily high voltages. Preferably such driving electrodes are provided substantially on one side of a channel. In one embodiment the driving electrodes extend around the wall of the channel.
  • [0076]
    In a preferred variant of the method above, one or more electrodes may be formed on a second substrate which is then laminated to the main support member of the device. Methods used to deposit the electrodes onto the second substrate may be chosen preferably from a printing method, more preferably a screen-printing method. Alternatively, chemical or physical vapour deposition techniques could be employed. Generally speaking, the electrodes according to all embodiments of the invention may be formed of any suitable inert material such as carbon, gold, platinum, etc. According to one embodiment, carbon electrodes, optionally coated with reagents are provided on the second substrate by screen-printing, which is then laminated onto the support member thus closing the channel or channels and two gold electrodes are provided adjacent one another on a substrate laminated onto the support member for an electro-osmotic pump.
  • [0077]
    If a second substrate is provided, preferably it is arranged to close the channel provided on the support member. This allows a very straightforward fabrication method in which electrodes are formed within a closed channel.
  • [0078]
    Lamination of one substrate to another will normally be carried out such that both laminates are perfectly aligned and that no further trimming or cutting is necessary. However, the device could be fabricated for example by firstly a lamination step followed by a cutting step whereby the second substrate may be trimmed to the shape of the support member. Lamination may be carried out by various methods such as ultrasonic or thermal welding or bonding, or by the use of an adhesive.
  • [0079]
    According to one embodiment, the support member is formed with an integral needle at one end and the second substrate is then laminated onto the support forming a channel and leaving the penetration member exposed. According to another embodiment the integrated skin penetration member is provided is open on one side. The penetration member is arranged so that upon insertion into skin, the skin itself effectively forms a wall of the member to that it can act like a hollow needle. Most preferably this is achieved by forming the penetration member with walls tapering away from the open side—e.g. a V shape. Thus when viewed from a further aspect the invention provides an apparatus for obtaining and measuring fluid , comprising a skin penetration member having at least one longitudinal side open, the other sides being arranged so as effectively to cause the penetrated skin to act as the remaining longitudinal side of the member when the penetration member is inserted into the skin.
  • [0080]
    Thus when viewed from a yet further aspect the present invention provides a method of fabricating a device for measuring the concentration of an analyte in a fluid comprising providing a support member, forming an open channel on a surface of the support member and laminating a second layer onto said support member so as to close said channel. The invention also extends to a device fabricated using such a method.
  • [0081]
    Where an optical measurement technique is employed, as an alternative to an electrochemical measurement technique a light sensing means will, in general, be required. In some cases a light source may also be required, but is not always the case, for example in the case of chemiluminescent measurement. Any such light sensing means and/or the light source may be provided integrally with the non-disposable measuring device e.g. a test-meter. According to one embodiment it or they are provided separately of the part of the device which is brought into contact with the sample fluid—e.g. a skin patch. This means that the device itself can be made disposable while the relatively more expensive light sensing means and associated electronics for example could be provided in a separate test meter.
  • [0082]
    In preferred embodiments the test device comprises means for optimising the light transfer from the sensing means to the optically sensitive means. In a simple embodiment such means comprises a lens, e.g. integrally moulded as part of the support member for the test device. Additionally or alternatively the device may be arranged such that the light sensitive means views the sensing means along the conduit, e.g. microchannel, along which the sample fluid passes. In other words the conduit, preferably a microchannel, acts as a light pipe.
  • [0083]
    By measuring light transmission or reflectance along the microchannel rather than across it, the path length and therefore the optical density may be increased for a minimal sample volume. , thereby making its measurement easier and more accurate. The material from which the conduit is formed is preferably chosen so to maximise light throughput at the frequencies of interest.
  • [0084]
    It will be appreciated by those skilled in the art that the arrangement described above is beneficial in its own right in enhancing the signal that may be measured from a minimal sample volume and thus when viewed from a yet further aspect the present invention provides an apparatus for measuring the light from an assay comprising an elongate conduit portion along which a sample fluid is drawn in use and a light sensitive means arranged to be sensitive to light coming substantially from the longitudinal axis of said conduit portion.
  • [0085]
    In one particularly preferred embodiment a disposable skin patch is provided with a moulded plastics lens over the analyte sensing means. A corresponding test meter is designed to be placed over the patch and comprises a light sensitive element which sits over the lens when the meter is placed over the patch.
  • III. BRIEF DESCRIPTION OF THE DRAWINGS
  • [0086]
    Certain preferred embodiments of the invention will now be described, by way of example only, with reference to the accompanying drawings in which:
  • [0087]
    [0087]FIG. 1 shows a first embodiment of the invention, in the form of a skin patch, in cross section;
  • [0088]
    [0088]FIG. 2a shows an alternative microchannel arrangement;
  • [0089]
    [0089]FIG. 2b shows a multiple channel/sensor arrangement;
  • [0090]
    [0090]FIG. 3 depicts a cross section view of the skin patch of FIGS. 1, and 2 attached to the skin of the user with a controller unit attached to the skin patch;
  • [0091]
    [0091]FIG. 4 depicts a display unit;
  • [0092]
    [0092]FIG. 5 depicts another embodiment of the invention, showing schematically a skin patch integrated with a needle, which also acts as an electrode, in cross section;
  • [0093]
    [0093]FIG. 6a depicts a microchannel and optochemical sensor in plan view;
  • [0094]
    [0094]FIG. 6b depicts a microchannel and electrochemical sensor in plan view;
  • [0095]
    [0095]FIGS. 6c to e are cross sections of the microchannel of FIG. 6b with fluid progressively entering the channel;
  • [0096]
    [0096]FIG. 8a shows a further embodiment of the invention, in the form of a single-use device with an integrated puncturing means;
  • [0097]
    [0097]FIG. 8b is a cross section through a user's skin having the device of FIG. 8a therein;
  • [0098]
    [0098]FIGS. 8c and 8 d depict the construction of a device similar to that in FIG. 8a;
  • [0099]
    [0099]FIG. 8e is an alternative embodiment, shown in perspective view, of a puncturing means;
  • [0100]
    [0100]FIG. 8f is a still further embodiment of an alternative puncturing means shown in perspective view;
  • [0101]
    [0101]FIG. 8g is a side-sectional view of the embodiment of FIG. 8f taken along line X-X in FIG. 8f;
  • [0102]
    [0102]FIG. 8h is a cross-sectional view of the lance of FIG. 8e in tissue;
  • [0103]
    [0103]FIG. 8i shows an integrally formed base member and lance showing a vent and a capillary sensing channel, but with upper laminate removed for clarity;
  • [0104]
    [0104]FIG. 12a is a perspective view of a microchannel,
  • [0105]
    [0105]FIG. 12b is a close-up, partial, perspective view of a microchannel; whereby electrodes are provided on opposing sides of a fluid channel by forming a first channel which is filled with a conductive material, and forming a second channel for conveying the test fluid, the second channel cutting across the first thereby thereby forming two conductive portions within respective opposite sides of the second channel.
  • [0106]
    [0106]FIG. 17a is top view, taken in perspective, of a first preferred embodiment of a chip for extracting and distributing a fluid sample and having a meander shaped waste reservoir;
  • [0107]
    [0107]FIG. 17b is the view of the embodiment of FIG. 17a modified to illustrate a column shaped waste reservoir; FIG. 18 is a bottom view, taken in perspective, of the chip of FIG. 17a;
  • [0108]
    [0108]FIG. 19 is a plan view of a measurement channel of the chip of FIG. 17a;
  • [0109]
    [0109]FIG. 20a is a plan view of the meander shaped waste reservoir of the embodiment of FIG. 17a;
  • [0110]
    [0110]FIG. 20b is a plan view of the column shaped waste reservoir of the embodiment of FIG. 17b; and
  • [0111]
    [0111]FIG. 21 is a plan view of the switching mechanism shown in FIG. 20a.
  • IV. Detailed Description of the Drawings
  • [0112]
    A. Skin Patch—General Description
  • [0113]
    Turning to FIG. 1 there is shown a skin patch 2 suitable for measuring the level of blood glucose in a user. Patch 2 is made up of two layers 3 a and 3 b
  • [0114]
    The lowermost layer 3 a is made of an suitable microfabricated plastic such as polyester, polycarbonate, polystyrene, polyimide, or other suitable microfabricatable polymers of suitable dimensions to allow it to be worn comfortably for a prolonged period of time, and optionally has an adhesive on its underside to allow the patch to be securely attached to the skin of a user. An optional pressure ring (5) is designed to apply pressure to the surface of the skin to enhance the flow of fluid from the body of the patient into the device. The pressure means may also be integrally formed and of the same material as that of 3 a. The drawing is not to scale and thus the various features may be of a different relative thickness dimension than illustrated. It is understood that FIG. 1 is shown for illustrative purposes only and as such the underside of 3 a may be of any shape that would facilitate fixing of the device to the skin, for example when the pressure means is incorporated. The invention is not limited as such to a pressure ring and other types of pressure extraction designs could be used. A penetration device (4) e.g. a needle, lancet or cannula is attached to the lowermost layer 3 a, through which fluid passes into the collection and fluid collection and distribution port (7) formed in the upper surface of layer 3 a. Layer 3 a has on its upper surface microfabricated channels. Port (7) is also formed by the same microfabrication process as the microchannels.
  • [0115]
    Laminated to the lowermost layer is a substrate layer 3 b, preferably formed of the same material as that of the lowermost layer. This serves to close the microchannel. The microchannel and penetration member may optionally be coated with a hydrophilic material and/or an anti-coagulant such as a heparin attached to the inner surface such that during use it will not diffuse away. Also shown is the microchannel system 8, corresponding electrochemical detectors 11 and optionally the electro-osmotic pump systems 10 and the hydrophobic gates 12 Each of the electrochemical detectors 12 and electro-osmotic pump systems 10 are electrically connected via conductive tracks (not shown) to respective terminals (not shown) at the edge of the patch. Not shown in FIG. 1 are the fluid reservoirs. FIG. 2a shows another embodiment whereby hydrophobic gates are present on either side of the sensor.
  • [0116]
    With respect to FIG. 3, a controller unit 102 is brought into contact with these terminals so as to make electrical contact in use in order to transmit the measurement output signals between the patch and a display unit 103 (see FIGS. 3 and 4).
  • [0117]
    A control unit 102 for the patch 2 is shown in FIG. 3. As may be seen, this sits on top of the patch 2 and is secured to upper side of the patch in a suitable manner(not shown). The control unit serves to control the fluid pumping mechanism, hydrophobic gates, fluid switching means and analyte sensors. The control unit is also provided with means such that radio frequency communication may be made, for example with the meter, for transmission and receipt of data. The control unit would also determine when all the microchannel/sensors had been used and transmit a signal accordingly. The control unit would also have means to detect any malfunctioning of the device and to also transmit this information.
  • [0118]
    The control unit 102 is preferably battery operated and is capable of transmitting signals to a wireless display unit (FIG. 4) for example a radio frequency communication.
  • [0119]
    [0119]FIG. 2b shows a multichannel arrangement with the proximal end of the needle 4 is in fluid communication with a fluid collection and distribution port (7) formed in the substrate layer 3 b of the patch. Radiating out from the manifold 6 are eighteen of the microchannel systems 8. Not shown is the fluid switching means.
  • [0120]
    B. Micro-Channel System with Flow Control
  • [0121]
    One such microchannel system 8 is shown in greater detail in FIG. 6b. The microchannel 608 is in direct communication with the port 607 into which the fluid flows from the needle 4. Downstream of the port 607 is an electrode system comprising a pair of inert electrodes 610 providing electrosmotic flow. The electrodes are formed on a second substrate layer 3 b (omitted from this figure for clarity). The second substrate layer is then laminated onto the first substrate layer 3 b thereby closing the microchannel 126 and bringing the electrodes 610 into contact with it. The electrodes 610 are positioned adjacent to each other, together forming an electro-osmotic pump system. By applying a voltage difference across the electrodes, an electric field is generated which drives fluid along the microchannel 608.
  • [0122]
    Positioned along the microchannel 608 is one or more hydrophobic gates 612 which prevents the flow of fluid by capillary action along the microchannel. Downstream of the hydrophobic gate 128 is an electrochemical sensor 611 comprising at least two electrodes also formed on the upper substrate layer 3 b. At least one further hydrophobic gate similar to the first, is optionally provided downstream of the sensor 12. This serves to stop the flow of fluid past the electrodes to allow the possibility for an end-point detection of the analyte. It will be understood by those skilled in the art that the hydrophobic gates may be constructed of any suitable material, including, but not limited to, PTFE, polycarbonate, polyisobutelene, PMMA, dodecyl acetate, silicon rubber, synthetic way, octadocyl mercaptane, dodecyl mercaptane, and/or octa decyltrichloro silane.
  • [0123]
    C. Skin Patch Operation
  • [0124]
    Operation of the skin patch 2 will now be described. The patch is attached to the skin of a user causing the needle 4 to penetrate substantially into the cutaneous layer of skin. Cutaneous fluid is drawn up the needle 4 and into the port 7 of the device. Referring now to FIG. 6c it will be seen that the fluid 136 is drawn into the microchannel 126 as far as the hydrophobic gate 128 where its flow is arrested. When a measurement is required, the controller unit 102 issues an appropriate signal to the electro-osmotic pump 610, in the form of a voltage difference across the two electrodes. This causes the fluid 136 to flow through the hydrophobic gate 128 and past the analyte sensor 611 until it reaches the second (optional) gate . Once the interstitial fluid 136 comes into contact with the sensor 12, a measurement is performed by the analyte sensors.
  • [0125]
    The controller unit 102 is provided with control means or means to initiate the flow of interstitial fluid sequentially to each of the microchannels (8) after a predetermined period of time. Once all the tests on the patch 2 have been performed, the controller 102 transmits a signal to the display means 103 to alert the user so that the patch 2 can be discarded and a fresh one applied.
  • [0126]
    D. Alternative Embodiment with Optochemical Sensing
  • [0127]
    An alternative form of microchannel 126 is shown in FIG. 6a. This is similar to that shown in FIG. 6b except that the electrochemical sensor 611 is replaced by an optochemical one 615. The optical sensor comprises a reaction chamber 616 which for example contains Glucose oxidase (GOD) Horseradish Peroxidase (POD) and a leuco-dye, (a colourless precursor of the dye molecule). (e.g. 2,2-Azino-di-[3-ethylbenzthiazoline-sulfonate] The optical system is not limited to the above example and could comprise any suitable enzyme-dye combinations. The reaction which takes place is as below:
  • [0128]
    It will be seen from the above that the dye changes
  • [0129]
    colour in accordance with the amount of glucose in the sample. In order to measure this, the chamber 129 has an optically transparent upper surface. This arranged is to be aligned with the tip of an optical fibre in a modified control unit (not shown) so that the fibre is approximately 2 to 3 mm above the dye spot. The other end of the fibre is in optical contact with a light source and light sensitive diode sensor which is sensitive to a particular wavelength of light (for example 438 nm in the case of ABTS) emitted by the transformed dye. The degree of absorption therefore gives a measure of the amount of transformed dye and thus the amount of glucose present.
  • [0130]
    As illustrated above, glucose present in the fluid acts as a substrate for GOD, which breaks the glucose down into glucono-1,5-lactone and hydrogen peroxide. POD subsequently catalyses the oxidation of the leuco-dye using the hydrogen peroxide, resulting in the production of a coloured dye which is subsequently detected. Those skilled in the art will understand that instead of 2,2-Azino-di-[3-ethylbenzthiazoline-sulfonate], any suitable leuco-dye may be used, e.g. Tetramethylbenzidine-Hydrochloride, or 3-Methyl-2-Benzothiazoline-Hydrazone in conjunction with 3-Dimethylamino-Benzoicacide.
  • [0131]
    The microchannels described as hereinbefore use electrochemical or colorimetric means to detect glucose. The skilled person would understand that other detection means, such as infra red detection, filter photometry or Kromoscopy may be used.
  • [0132]
    F. Electrode Penetration Member
  • [0133]
    [0133]FIG. 5 shows schematically a further preferred embodiment of the invention. similar construction to that of the previous embodiments and thus it has a hollow needle 106, for example but not limited to 1.4 mm long and 0.3 mm wide which penetrates substantially the cutaneous layer of the skin 113 of the user.
  • [0134]
    In this embodiment however the needle 106 also acts as an electrode which serves to extract fluid from the skin. At least one electrode 108 is provided such it makes contact with the skin. As shown in FIG. 5, the needle is poised at a positive potential. By applying a voltage difference across the electrodes 106 and 108 an electric field is generated along the needle 106 and manifold 111 which stimulates the skin and increases the perfusion of interstitial fluid out of the skin.
  • [0135]
    G. Alternative Penetration Member Construction
  • [0136]
    [0136]FIGS. 8a to 8 d show two further embodiments of the invention. In contrast with the foregoing embodiments, these are both single-use strips suitable for measuring blood glucose of a user. They are therefore used in a similar way to conventional test strips. However a principle difference is that each has an integrated lance 119 at one end.
  • [0137]
    Considering the device 115 shown in FIG. 8a, it will be seen that it is made essentially of a layer 116 onto which a second layer is attached or laminated (not shown). The lowermost substrate layer 116 comprises a moulded or stamped microchannel 118, as well as the integrally formed lance 119 arranged in close proximity with the entrance 103 of the microchannel. During manufacture, the microchannel 118 maybe coated with suitable reagents, such as glucose oxidase in the case of glucose detection, which can be applied by any conventional means, such as printing for example screen-printing or ink-jet printing, or spray coating during manufacture. Alternatively, the microchannel may be free of enzyme, the reagents being provided on the electrode system (121) located on the underside of the uppermost layer (117).
  • [0138]
    The uppermost layer 117 may also be a conventional biosensor test-strip which could be attached to the lower surface such that the electrodes are positioned on the underside of the formed channel. This particular electrode system 121 comprises three electrodes 221 of which at least one is covered with layers of enzyme and electron mediator such as glucose oxidase and ferricyanide to form a working electrode for detecting glucose, as is well known in the art, the other two being a counter and reference electrode. The electrode system may comprise two working electrodes which serve to compare currents at each and measure the channel filling speed of the blood or interstitial fluid. Alternatively the electrode system could comprise just two electrodes, a working and counter/reference. Not shown in FIGS. 1-21 is a venting device such that air may be displaced upon uptake of fluid into the microchannel. A vent or vents may be provided at any convenient location. Corresponding tracks 321 allow electrical connection to be made to the electrodes at the distal end of the strip when it has been inserted into a suitable test meter. The upper layer 117 may be slightly longer than the lower one 116 to allow access to the tracks 321 for this purpose.
  • [0139]
    It will be noticed in particular that the lance 119 of the strip 115 in FIG. 8a is essentially V shaped in cross section and tapers towards its tip. This means that when it is used to puncture a user's skin 123, as is shown in FIG. 8b, the two sides of the V force back a portion of the skin 123, forcing the epidermis to form the remaining wall 123 of an enclosed channel 124. Thus an open channel is effectively transformed into a closed one when it is inserted into skin. This allows fluid to be drawn up the channel 124 so formed and into the microchannel 118, without having to mould a very fine hollow needle. The microchannel 118 may also be formed with a V shaped profile for convenience of fabrication, but this is not essential as may be seen from the slightly modified embodiment of FIGS. 8c and 8 d in which the microchannel 118′ has a rectangular profile.
  • [0140]
    In the use of the strip 115, the user pierces their skin with the lance 119 and interstitial fluid or blood is made to flow, by means of capillary action, through channel 124 formed by the lance (119) and the skin 122, into the microchannel 118 and thus over the electrochemical detector 121.
  • [0141]
    The user then withdraws the strip 115 and inserts the opposite end into a conventional style test meter which makes electrical connection to the three conductive tracks 321. Preferably however, the meter is an integral part of the lancing system such that the user does not need to insert the strip into the meter and is automatically provided with the measurement result.
  • [0142]
    [0142]FIGS. 8e through 8 h show alternative embodiments of lances for penetrating into a body-fluid laden layer of skin as an alternative to the embodiment of the lance 119 of FIGS. 8a and 8 b. In FIG. 8e, the lance 119 a is an integrally formed pointed protrusion from the device 115 (not shown in FIGS. 8e but identical to that in Fog. 8 a) with a longitudinal capillary channel 121 a cut completely through the thickness of the lance 119 a. At a pointed distal tip 125 a of the lance 119 a, the lance 119 a is provided with an enlarged area 123 a of the channel 121 a. The enlarged area 123 a also is cut completely through the thickness of the lance 119 a. At its proximal end 127 a, the capillary channel connects with the microchannel 118 of the device 115 of FIG. 8a.
  • [0143]
    As shown best in FIG. 8h, the embodiment of FIG. 8e permits fluid to enter into the capillary channel 121 a from opposite sides of the lance 119 a and with the wall of the skin cooperating with the walls of the lance 119 a to define an enclosed channel 121 a. Fluid then can accumulate in the pooling area 123 a and flow from the pooling area 123 a into the capillary channel 121 a as well as flow directly from the skin into the capillary channel 121 a for passage to the microchannel 118.
  • [0144]
    In the embodiment of FIG. 8f, a lance 119 b is of a design similar to that of FIG. 8e is shown but excluding the large pooling area 123 a. Elimination of the pooling area 123 a permits a narrower transverse dimension to the lance 119 b.
  • [0145]
    In addition to fabricating the device from molded parts, the base member 116 and lances 119, 119 a, 119 b can be stamped from electrically conductive material. In such cases, the base member may be an electrode. An electrically conductive base member and lance can be stamped from metal as described or formed in any other acceptable manner (e.g., photochemically etching a metal stock material, machining or other fabricating technique). While the electrically conductive base member can be made of stainless steel it can be also be plated with a second metal such as for example gold platinum or silver. The electrically conductive base material may also be used as a counter electrode.
  • [0146]
    [0146]FIG. 8i shows an integrally formed base member and lance stamped from preferably one piece of sheet metal. The metal is preferably, but not limited to, stainless steel optionally coated with a noble metal such as gold or silver. Also shown on the base sheet is a microchannel 84 onto which a second layer such as a test-strip could be attached. It is intended that such a device as illustrated in FIG. 8i would be incorporated into a lancet firing device such that the device could be fired into the skin. Furthermore the individual devices may be loaded and stored in a cassette comprising individually sealed pouches. Such a cassette could also be stored within the lancet firing device.
  • [0147]
    The stamped penetration member with a rectangular vent 81 which also serves as a capillary break ensuring that once fluid is taken up by the lance 83 into the sensing zone 82, the flow of fluid is halted. The vent may be of any suitable size or shape.
  • [0148]
    J. Detailed Preferred Embodiment
  • [0149]
    1. Sampling Module
  • [0150]
    With reference now to FIGS. 17a-21, the present invention will now be described with reference to a most preferred embodiment of the invention in an ex vivo continuous monitoring system.
  • [0151]
    The ex vivo continuous monitoring system consists of several major subsystems including sample extraction, sample fluid distribution, and electrochemical detection. As will be more fully described below, a body fluid sample can be extracted from the skin and guided into a channel for the electrochemical determination of glucose concentration.
  • [0152]
    After a predetermined period, the body fluid is directed into a different, previously unused channel. This process avoids false results otherwise arising from fouled electrodes or denaturant enzymes. Since the channels into which the fluid is re-directed are not filled with a sample solution or any other liquid, the electrochemical system in the channel will not show aging effects.
  • [0153]
    The disposable portion of the ex vivo continuous monitoring system is referred to herein as a chip. FIGS. 17a, 17 b show embodiments of such a chip 400, 400 a. In the embodiments of FIGS. 17a, 17 b, each chip 400, 400 a has for example, but not limited to, twelve measurement channels 402, 402 a with switching mechanism 404 and 404 a and waste reservoirs 406, 406 a. Differences in the embodiments of chips 400, 400 a will be described below with initial description being limited to a discussion of chip 400. It will be appreciated that chip 400 a is identical to chip 400 except as will be described. Similarly elements are numbered similarly with the addition of an “a” to distinguish embodiments.
  • [0154]
    The chip 400 has an edge connector 401 for electrically connecting electrodes (as will be described) to a controller (not shown). A controller can contain logic, memory and processors for controlling the electronics of the chip 400 and optionally displaying any outputs (as, for example, the function and operation of controller 102 in FIG. 3).
  • [0155]
    Preferably the measurement results are transmitted by radio frequency by the controller to a remote control allowing the user to view the result and optionally to communicate or interact with the controller of the monitoring system.
  • [0156]
    The sampling chip 400 extracts body fluid from the skin. In the preferred embodiment, the chip 400 extracts interstitial fluid (ISF) from substantially the cutaneous layer of a patient. With reference to FIG. 18, the chip 400 includes a suitable cannula or needle 410, a spring-loaded hub 412 to pressurize the skin and means such as an adhesive 414 to fix the chip 400 to the skin. Sampling modules with needles and spring-loaded hubs are shown in U.S. Pat. Nos. 6,203,504 and 5,746,217. It will be appreciated the foregoing description is a preferred embodiment. Any technique for obtaining a sample of body fluid may be used in combination with the teachings of the present invention.
  • [0157]
    Body fluid enters the needle 410 due to the pressure applied by the hub 412 and travels in to the micro-channels 402 as described above with reference to FIGS. 1a, 1 b and 2. The needle 410 discharges the body fluid into a common distribution depression 416 shown best in FIG. 19). The distribution depression 416 is in fluid flow with the micro-channels 402. In the embodiment shown (having 12 channels of the dimensions described, the shape and the volume to the distribution depression 416 is preferably a disk shaped void with 1 mm diameter and 100 μm depth. These dimensions and shape may vary depending upon the size, number and flow rate of individual channels. Not shown in the drawings, a portion of the micro-channel 402 between the distribution depression 416 and a ground or reference electrode 420 may be restricted in size to reduce flow rate variability and therefore control the rate of flow.
  • [0158]
    Means may be provided within the device for the removal of undesirable gas-bubbles from the fluid sample. Such means could comprise a filter positioned between the needle and the common reservoir.
  • [0159]
    2. Continuous Electrochemical Detection of Glucose
  • [0160]
    The electrochemical detection system consists of an electrode system shown best in FIG. 19. The electrode system includes at least one working electrode 418 (by way of non-limiting example, gold or carbon) and a reference electrode 420 (e.g., silver/silver-chloride). The reference electrode 420 is circular to serve as a common electrode for each channel 402, thus reducing the number of contacts necessary. Alternatively, each channel can be provided with a unique reference electrode. Each channel 402 has a unique dedicated working electrode 418. In addition, a counter electrode (not shown) may be added. The electrodes 418, 420 are disposed to contact fluid in the channel 402. As previously described, the channels 402 are formed as open channels in a substrate layer. The electrodes 420, 418 are screen-printed on an overlying laminate layer which also serves to seal the channels 402. The working electrode material is dependent on the enzyme ink being used. For example, one can distinguish between a redox-mediated system for the carbon working electrodes and an oxygen mediated system for the gold or platinum electrodes.
  • [0161]
    While a specific electro-chemical system will now be described, it will be appreciated that such description is illustrative and any suitable system could be used.
  • [0162]
    In the case of the redox-system, an organo-metal-complex (which is linked to polymers forming the ink body) acts as a conductor and electron acceptor for the enzyme. The electrons are transported by the redox-mediator directly or by an electron hopping mechanism from redox-center to redox-center to the working electrode. At the working electrode, the mediator is finally recycled to its original redox-state before it can react with the enzyme protein in a new cycle. The following are suitable for this detection method: glucose oxidase from aspergillus niger (GOD EC 1.1.3.4) and PQQ dependent glucose dehydrogenase (GDH EC 1.1.99.17).
  • [0163]
    The enzyme ink is a cross-linked hydrophilic gel allowing the penetration of sample fluid but restricting the movement of the enzyme thus it is fixed to the electrode. This is an important property of the enzyme ink because the concentration of the enzyme has an effect upon the total response of the sensor. The same effect can be observed with the redox-mediator, due to the small molecular weight it cannot be entrapped in the same way as enzymes. Therefore, in the preferred embodiment, it is preferred to link the redox-mediator molecule to the large molecules such as the enzymes, proteins, or to the polymers of the ink material directly. In case of oxygen-mediated systems the situation is simpler. The enzyme ink needs only to contain enzyme as active component, the oxygen itself is dissolved in the sample fluid and is transferred to the sensor from the sample stream in the same instance as glucose.
  • [0164]
    In case of glucose determination the oxygen-mediated system can be created with GOD based on the ability of the enzyme to build hydrogen peroxide from oxygen and glucose.
  • [0165]
    Oxygen-mediated:
  • [0166]
    Redox-mediated:
  • [0167]
    Ox=oxidized mediator species e.g. K3[Fe(CN)6], p-benzoquinon, Ferrocinium
  • [0168]
    Red=reduced mediator species e.g. K4[Fe(CN)6], hydroquinone, Ferrocene
  • [0169]
    Hydrogen peroxide is a very reactive molecule, which can function as mediator to transport electrons for the enzyme to the electrode surface.
  • [0170]
    Oxidation of hydrogen peroxide on gold:
  • [0171]
    Reduction of hydrogen peroxide on gold:
  • [0172]
    Normally only the oxidation of hydrogen peroxide is used for analytical purposes due to the possibility of direct oxygen reduction on negative polarized noble metal electrode during the reduction of hydrogen peroxide. However, the reduction of hydrogen peroxide would open the possibility to use more cost effective electrode materials such as silver instead of gold, platinum, or palladium. In comparison to the noble metal electrodes we need for the oxidation or reduction of hydrogen peroxide carbon electrodes can be used for the oxidation of the redox-mediator.
  • [0173]
    In the preferred embodiment, the electrodes are deposited on a film such as polystyrene or polycarbonate of about 10-200 μm and, more preferably, about 30 to 75 μm) using screen-printing technology. Subsequently to this print step the working electrode is coated with ink containing enzyme and in the case of carbon working electrodes with an ink containing enzyme and mediator.
  • [0174]
    This coating step could be accomplished with the same printing methods as used for the electrode material. Thus the production could be done in one machine with different print heads or stations on a continuous web. Such a process is described in “Continuous Process for Manufacture of Disposable Electrochemical Sensor”, U.S. patent application Ser. No. 09/537599.
  • [0175]
    3. Fluidic Elements of Ex Vivo Continuous Monitoring
  • [0176]
    A schematic diagram of one measurement channel 402 is shown in FIG. 19. The channel 402 extents from the needle 410 and distribution depression 416 and through the main channel 402 (of dimensions for example of 200 μm×100 μm) containing the electrodes 418, 420.
  • [0177]
    As previously described, a flow restricted portion of the channel 402 namely a small cross section (e.g., 30 μm×30 μm) may be provided between the distribution depression 416 and the common electrode 420. Such a flow restriction levels out different flow rates during the extraction of the body fluid. These flow rate differences are caused due to the changing physiological conditions during the extraction. In general, one could observe a higher flow rate at the beginning of a sampling period compared to the extraction rate at the end. A thin capillary can counter-act this behavior.
  • [0178]
    The electrodes 418, 420 are not part of the injection molded base plate of the chip 400. Instead, they are placed on top of the open U-shaped or rectangular channel 402 of the base plate of the chip 400 in a separate lamination step.
  • [0179]
    Extending from the measurement channel 402 is the waste reservoir 406. The waste reservoir 406 stores the sample solution after its evaluation by the electrochemical sensing in channel 402. The size of the waste reservoir 406 defines the amount of time one channel can theoretically be used. After the reservoir 406 is filled, the controller can activate the next channel to continue with the detection of glucose in the body fluid of a patient.
  • [0180]
    It is important that the reservoir 406 is large enough to support more then a two-hour measurement. Thus, a chip 400 with twelve channels 402 can run for 24 to 28 hours allowing the patient a convenient change to a new chip (e.g. during his daily morning routines). However, as will be appreciated by those skilled in the art, reservoirs 406 larger then 5 μL (which is enough to support the flow for more then two hours with a flow rate of 30 nL/min) could allow longer runtimes. Thus, the entire chip 400 could last for more than one day. The number of channels in a device is not limited and may vary depending upon the measurement technique, the length of monitoring period and the size of the device and could exceed 100.
  • [0181]
    [0181]FIGS. 20a, 20 b show two different representative embodiments of the waste reservoir 406, 406 a. Waste reservoir 406 is a meander-shaped extension of the channel 402. While easy to manufacture, such a design can build up high back pressure in the system, due to the weaker capillary force, then the design of waste reservoir 406 a and is not as space efficient.
  • [0182]
    The column filled reservoir 406 a has advantages compared to the meander-shaped reservoir 406 regarding the size and the integration into a 12-channel chip 400 a. It could be deeper than the reservoir 406 while producing a higher capillary force to take up the extracted and evaluated sample fluid from channel 402 a. In principle, waste channel 406 a resembles a plurality of capillaries with a cross-section for example of 400 μm×400 μm compared to only one-capillary with the same cross-section in the design of waste reservoir 406. The shape of the columns is not limited to simple squares. They could be formed as circles, pentagons, hexagons, octagons or the like. Concerning the flow characteristics inside a column field the hexagon shaped columns shown are the most preferred version. The size and geometry of the channels and reservoirs may vary.
  • [0183]
    The base plate of the chip 400 can be produced in a molding process, which is optimized for the small features and structures. A wide variation of plastics can be used for the base plate of the chip 400 (e.g. polystyrene, polycarbonate, polymethymethacrylate, polyester, and others). Preferred polymers are polycarbonates. These allow a subsequent laser finishing to generate a secondary micro- or nano-structure (e.g., any desired patterns or other finishing can be formed in the micro-channel). Polystyrene shows preferable characteristics in the lamination process. Thus polycarbonate could be used as the lower laminate and polystyrene used as the upper.
  • [0184]
    The chip 400 itself consists of three major part a) the chip base plate with all the fluidic elements described above, b) the electrochemical detection system screen printed on a polymer foil, and c) the sampling hub with extraction needle. These elements are described in the foregoing sections.
  • [0185]
    Normal lamination processes use foils coated with a pressure sensitive or hot melt adhesive to join a foil to a substrate or another foil. Such a standard process may present problems in conjunction with the described device. First, foil is needed which is suitable for the printing process. This is difficult with any pressure sensitive adhesive due to problems within the printing equipment. Such problems can be addressed with a foil coated with a hot melt adhesive, where the adhesive becomes tacky only at an elevated temperature (e.g. 80° C.). The deposition of ink to print the electrodes and other structures is quite easy with this system but it can present problems during the lamination step. The glue layer becomes substantially liquid at elevated temperatures with the consequence that the printed structure looses shape and gets stretched and deformed. Such deformation is not only a cosmetic problem for an electrode, it changes the electrode surface (which is directly proportional to the response signal) as well as the internal resistance of the material and the electro-catalytic properties.
  • [0186]
    Apart form the foregoing problems, there is the additional problem of glue entering and clogging or misshaping the channel. For the chip described above, the most advantageous process is an adhesive-free thermal bonding process of the pre-printed foil to the chip base plate. The bonding happens at an elevated temperature with a stamping tool or a hot roller press. The temperature is close to the glass transition temperature (Tg) of the polymer thus the low molecular weight portion of the polymer will become mobile and tacky while the high molecular weight portion of the polymer still supports the integrity of the foil or film. The low molecular weight portion of the polymer will bond both pieces (base plate and foil with electrodes) together, additionally it will follow the shape of the printed electrodes, which can be between 5 and 30 μm thick. Therefore, one does not see a leakage between base plates and printed areas. Ideal bonding is achieved with the same thermoplastic polymers such as polystyrene on polystyrene or polycarbonate on polycarbonate. However, with the right regime and temperature/pressure combination polycarbonate can be bonded on polystyrene as well. But duro-plastic (non thermoplastic) materials are not suitable for such a process.
  • [0187]
    4. Channel Switching Mechanism
  • [0188]
    The switching mechanism 404 allows the replacement of a used electrochemical system after a predetermined period of time. Generally, an electrochemical system is prone to fouling due to precipitation or adsorption of proteins or other species on the electrode surface.
  • [0189]
    In the past, many different systems have been developed to overcome this problem. A classical example for such a system is the mercury-drop-electrode, where the mercury provides the electrode surface but every second the drop of mercury is replaced. Thus, the system never undergoes a continuous fouling process of a solid-state electrode. The renewal of the electrode surface is the most efficient but also the most dramatic strategy to avoid fouling. However, this same concept is used with all current disposable diagnostic glucose strips, where the test strip is disposed after a relatively short working time (5 to 15 seconds depending on the device).
  • [0190]
    A different strategy is the protection of the electrode by a semi permeable membrane, which allows the analyte to pass through to the electrode but not a large protein (or a red blood cell). This concept is adopted in classical oxygen electrodes.
  • [0191]
    The chip 400 uses a mixture of both concepts: a plurality of electrodes in diff rent channels as well as an electrode protected by screen printable membrane (see German patent DE10052066.9 and related International patent application PCT/EP01/12073). This allows the sensor electrodes to operate for several hours before the fouling shows a significant effect on the results and before the controller is switching to the next channel.
  • [0192]
    [0192]FIG. 21 shows a schematic diagram of the switching mechanism 404. At the beginning of a measurement, all channels 402 are filled with air and the entrance of fluid into the channel 402 from the distribution depression 416 is blocked due to the gas back pressure. The switching system 404 includes electrodes 422 separate from the electrochemical detector electrodes 418, 420. The switching electrodes 404 allow local heating of a very small area on the thin foil such as polystyrene 424 overlying a well 426. The well 426 is in fluid flow communication with the end of the reservoir 406 except that the fluid flow is normally blocked by the foil 424. Due to this blockage, air cannot escape from the channel 402 and fluid from the distribution depression 416 cannot flow into the channel 402. Upon heating of the foil, this blockage is removed thus allowing the fluid to enter the channel.
  • [0193]
    The temperature at the center point of the overlying electrodes 422 (i.e., overlying the foil 424 above the well 426) very quickly rises over the glass transition temperature (Tg) of the foil in response to an application of a small current in the range of some {fraction (1/1000)} Ampere with the effect that the foil 424 forms an opening above the hydrophobic well 426 allowing air in the channel 402 and reservoir 406 to vent into the well 426. In this event, the gas pressure in the channel 402 is relieved and fluid can flow from the distribution depression 416 and into the channel 402.
  • [0194]
    The hydrophobicity of the well 426 prevents the sample fluid from flowing into the well 426 and leaking out of an opening formed in the film by reason of the energized electrodes 404. After the waste reservoir 406 is filled completely, the controller opens a subsequent channel 402 by energizing its switching electrodes 422 to permit air to escape from the channel 402 and for the subsequent channel 402 to fill with body fluid. It should be appreciated that other methods for switching between channels and controlling fluid flow could be used and the invention is not limited by the above method
  • [0195]
    5. Flow Rate Detection
  • [0196]
    To assure a safe operation, it is preferable the controller determine if the waste reservoir 406 is filled, is still filling at a constant rate, or if the needle 410 has dislodged from the cutaneous layer of the patient and the continuous sample stream has stopped. To achieve this, the waste reservoir 406 can be equipped with two electrodes (not shown) at the top and the bottom of the reservoir. Not in electrical contact with the sample fluid, these electrodes could measure the change in capacitance while the air inside the structure is slowly exchanged with sample fluid. The rate of the capacitance change will be directly proportional to the flow rate of the sample fluid and allow a close monitoring of the ongoing extraction.
  • [0197]
    6. Semi-Continuous Monitoring Alternative
  • [0198]
    An alteration of the foregoing is the scheduled measurement of discrete glucose values. With this embodiment the waste reservoir is just large enough to replace the dead volume of the needle and sampling module but instead of for example twelve channels the chip contains a higher number of channels (e.g. 72 or 144 channels). These structures would support a 12-hour or 24-hour measurement cycle with a discrete glucose test very 10 minutes. An advantage of the semi-continuous method would be that it would not be necessary to use a cross-linked hydrogel due to the fact that migration of the reagents into the fluid sample over time would no longer an issue. Consequently, conventional enzyme inks such as disclosed in U.S. Pat. No. 5,708,247 could be used.
  • [0199]
    It will be appreciated by those skilled in the art that whilst some of the potential embodiments of the inventive concepts disclosed herein have been described in greater detail, there are many different variations and modifications to these possible. For example, devices in accordance with the invention may measure the concentration of analytes other than those in bodily fluids.
Citations de brevets
Brevet cité Date de dépôt Date de publication Déposant Titre
US3699437 *21 août 196917 oct. 1972Ur AmiramBlood coagulation detection method and apparatus
US4758884 *19 mai 198619 juil. 1988Kaiser ElectronicsElectronically switched field sequential color video display having parallel color inputs
US5039617 *20 avr. 198913 août 1991Biotrack, Inc.Capillary flow device and method for measuring activated partial thromboplastin time
US5300779 *18 août 19925 avr. 1994Biotrack, Inc.Capillary flow device
US5328847 *18 nov. 199112 juil. 1994Case George DThin membrane sensor with biochemical switch
US5344754 *13 janv. 19936 sept. 1994Avocet Medical, Inc.Assay timed by electrical resistance change and test strip
US5534226 *19 avr. 19959 juil. 1996International Technidyne CorporationPortable test apparatus and associated method of performing a blood coagulation test
US5577499 *3 oct. 199426 nov. 1996Teves; Leonides Y.Blood analyzer
US5591139 *6 juin 19947 janv. 1997The Regents Of The University Of CaliforniaIC-processed microneedles
US6084880 *30 juin 19974 juil. 2000Efficient Networks, Inc.Asynchronous transfer mode adapter for desktop applications
US6090323 *6 févr. 199818 juil. 2000Navitas Co., Ltd.Method for manufacturing card product
US6312393 *29 févr. 20006 nov. 2001Marcio Marc A. M. AbreuContact device for placement in direct apposition to the conjunctive of the eye
US6540675 *20 déc. 20001 avr. 2003Rosedale Medical, Inc.Analyte monitor
US6887202 *30 mai 20013 mai 2005Science Applications International CorporationSystems and methods for monitoring health and delivering drugs transdermally
US7344499 *2 déc. 199918 mars 2008Georgia Tech Research CorporationMicroneedle device for extraction and sensing of bodily fluids
Référencé par
Brevet citant Date de dépôt Date de publication Déposant Titre
US705935230 mars 200513 juin 2006Lifescan ScotlandTriggerable passive valve for use in controlling the flow of fluid
US715611730 mars 20052 janv. 2007Lifescan Scotland LimitedMethod of controlling the movement of fluid through a microfluidic circuit using an array of triggerable passive valves
US716911720 sept. 200530 janv. 2007Lifescan, Inc.Integrated lance and strip for analyte measurement
US728807330 août 200130 oct. 2007Roche Diagnostics Operations, Inc.System for withdrawing small amounts of body fluid
US7291497 *10 sept. 20046 nov. 2007Theranos, Inc.Medical device for analyte monitoring and drug delivery
US731054326 mars 200118 déc. 2007Kumetrix, Inc.Silicon microprobe with integrated biosensor
US747326414 oct. 20056 janv. 2009Lifescan, Inc.Integrated lance and strip for analyte measurement
US763559424 mars 200622 déc. 2009Theranos, Inc.Point-of-care fluidic systems and uses thereof
US766530330 mars 200523 févr. 2010Lifescan Scotland, Ltd.Method of segregating a bolus of fluid using a pneumatic actuator in a fluid handling circuit
US767940727 avr. 200416 mars 2010Abbott Diabetes Care Inc.Method and apparatus for providing peak detection circuitry for data communication systems
US775656130 sept. 200513 juil. 2010Abbott Diabetes Care Inc.Method and apparatus for providing rechargeable power in data monitoring and management systems
US77668294 nov. 20053 août 2010Abbott Diabetes Care Inc.Method and system for providing basal profile modification in analyte monitoring and management systems
US776840817 mai 20063 août 2010Abbott Diabetes Care Inc.Method and system for providing data management in data monitoring system
US781123126 déc. 200312 oct. 2010Abbott Diabetes Care Inc.Continuous glucose monitoring system and methods of use
US78155792 mars 200519 oct. 2010Roche Diagnostics Operations, Inc.Dynamic integrated lancing test strip with sterility cover
US782433331 mars 20062 nov. 2010Lifescan, Inc.Diabetes management methods and systems
US78605447 mars 200728 déc. 2010Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US78698536 août 201011 janv. 2011Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US78847292 août 20108 févr. 2011Abbott Diabetes Care Inc.Method and system for providing data management in data monitoring system
US78856996 août 20108 févr. 2011Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US788749430 sept. 200515 févr. 2011Intuity Medical, Inc.Fluid sample transport devices and methods
US788812524 mars 200615 févr. 2011Theranos, Inc.Calibration of fluidic devices
US79209077 juin 20075 avr. 2011Abbott Diabetes Care Inc.Analyte monitoring system and method
US792245829 déc. 200812 avr. 2011Abbott Diabetes Care Inc.Variable volume, shape memory actuated insulin dispensing pump
US79288508 mai 200819 avr. 2011Abbott Diabetes Care Inc.Analyte monitoring system and methods
US793506320 oct. 20063 mai 2011Roche Diagnostics Operations, Inc.System and method for breaking a sterility seal to engage a lancet
US794938227 juil. 201024 mai 2011Arkal Medical, Inc.Devices, systems, methods and tools for continuous glucose monitoring
US795527113 oct. 20067 juin 2011Roche Diagnostics Operations, Inc.Tape transport lance sampler
US797677822 juin 200512 juil. 2011Abbott Diabetes Care Inc.Blood glucose tracking apparatus
US799310813 avr. 20059 août 2011Abbott Diabetes Care Inc.Variable volume, shape memory actuated insulin dispensing pump
US799310929 déc. 20089 août 2011Abbott Diabetes Care Inc.Variable volume, shape memory actuated insulin dispensing pump
US799328420 sept. 20079 août 2011Roche Diagnostics Operations, Inc.System for withdrawing small amounts of body fluid
US80079999 mai 200730 août 2011Theranos, Inc.Real-time detection of influenza virus
US802924529 déc. 20084 oct. 2011Abbott Diabetes Care Inc.Variable volume, shape memory actuated insulin dispensing pump
US802925029 déc. 20084 oct. 2011Abbott Diabetes Care Inc.Variable volume, shape memory actuated insulin dispensing pump
US802945921 déc. 20094 oct. 2011Abbott Diabetes Care Inc.Method and system for providing integrated medication infusion and analyte monitoring system
US802946021 déc. 20094 oct. 2011Abbott Diabetes Care Inc.Method and system for providing integrated medication infusion and analyte monitoring system
US804781129 déc. 20081 nov. 2011Abbott Diabetes Care Inc.Variable volume, shape memory actuated insulin dispensing pump
US804781229 déc. 20081 nov. 2011Abbott Diabetes Care Inc.Variable volume, shape memory actuated insulin dispensing pump
US80666394 juin 200429 nov. 2011Abbott Diabetes Care Inc.Glucose measuring device for use in personal area network
US80893637 févr. 20113 janv. 2012Abbott Diabetes Care Inc.Method and system for providing data management in data monitoring system
US809239413 sept. 200510 janv. 2012Microsample Ltd.Method and apparatus for sampling and analysis of fluids
US810140212 août 200524 janv. 2012Theranos, Inc.Medical device for analyte monitoring and drug delivery
US810345629 janv. 200924 janv. 2012Abbott Diabetes Care Inc.Method and device for early signal attenuation detection using blood glucose measurements
US811213826 sept. 20087 févr. 2012Abbott Diabetes Care Inc.Method and apparatus for providing rechargeable power in data monitoring and management systems
US811224029 avr. 20057 févr. 2012Abbott Diabetes Care Inc.Method and apparatus for providing leak detection in data monitoring and management systems
US81236861 mars 200728 févr. 2012Abbott Diabetes Care Inc.Method and apparatus for providing rolling data in communication systems
US814911729 août 20093 avr. 2012Abbott Diabetes Care Inc.Analyte monitoring system and methods
US81584306 août 200817 avr. 2012Theranos, Inc.Systems and methods of fluidic sample processing
US816282930 mars 200924 avr. 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US81756739 nov. 20098 mai 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US817771621 déc. 200915 mai 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US818718311 oct. 201029 mai 2012Abbott Diabetes Care Inc.Continuous glucose monitoring system and methods of use
US8192360 *25 sept. 20075 juin 2012Pacesetter, Inc.Implantable body fluid analyzer
US820269712 août 200519 juin 2012Theranos, Inc.Medical device for analyte monitoring and drug delivery
US822441310 oct. 200817 juil. 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US822655518 mars 200924 juil. 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US822655728 déc. 200924 juil. 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US822655827 sept. 201024 juil. 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US822689131 mars 200624 juil. 2012Abbott Diabetes Care Inc.Analyte monitoring devices and methods therefor
US823153230 avr. 200731 juil. 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US823183214 août 200831 juil. 2012Intuity Medical, Inc.Analyte concentration detection devices and methods
US823589621 déc. 20097 août 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US823624212 févr. 20107 août 2012Abbott Diabetes Care Inc.Blood glucose tracking apparatus and methods
US825503117 mars 200928 août 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US82603929 juin 20084 sept. 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US82657269 nov. 200911 sept. 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US826824328 déc. 200918 sept. 2012Abbott Diabetes Care Inc.Blood glucose tracking apparatus and methods
US827302213 févr. 200925 sept. 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US82754399 nov. 200925 sept. 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US82831558 oct. 20099 oct. 2012Theranos, Inc.Point-of-care fluidic systems and uses thereof
US828745427 sept. 201016 oct. 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US829309622 janv. 201023 oct. 2012Lifescan Scotland LimitedSystems and methods for determining a substantially hematocrit independent analyte concentration
US83065989 nov. 20096 nov. 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US832872011 août 200811 déc. 2012Infotonics Technology Center, Inc.MEMS interstitial prothrombin time test
US83287362 juin 201111 déc. 2012Roche Diagnostics Operations, Inc.Tape transport lance sampler
US833371410 sept. 200618 déc. 2012Abbott Diabetes Care Inc.Method and system for providing an integrated analyte sensor insertion device and data processing unit
US834307430 juin 20041 janv. 2013Lifescan Scotland LimitedFluid handling devices
US834309224 nov. 20091 janv. 2013Abbott Diabetes Care Inc.Method and system for providing integrated medication infusion and analyte monitoring system
US834309328 mai 20101 janv. 2013Abbott Diabetes Care Inc.Fluid delivery device with autocalibration
US834496631 janv. 20061 janv. 2013Abbott Diabetes Care Inc.Method and system for providing a fault tolerant display unit in an electronic device
US834633618 mars 20091 janv. 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US834633730 juin 20091 janv. 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US835382921 déc. 200915 janv. 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US835709121 déc. 200922 janv. 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US83609933 août 201129 janv. 2013Intuity Medical, Inc.Method for body fluid sample extraction
US83609943 août 201129 janv. 2013Intuity Medical, Inc.Arrangement for body fluid sample extraction
US836290418 avr. 201129 janv. 2013Abbott Diabetes Care Inc.Analyte monitoring system and methods
US836661430 mars 20095 févr. 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US837200521 déc. 200912 févr. 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US838027311 avr. 200919 févr. 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US838268129 sept. 200626 févr. 2013Intuity Medical, Inc.Fully integrated wearable or handheld monitor
US838855230 juin 20115 mars 2013Roche Diagnostics Operations, Inc.System for withdrawing small amounts of body fluid
US83888215 oct. 20075 mars 2013Lifescan Scotland LimitedMethod for determining hematocrit corrected analyte concentrations
US839194517 mars 20095 mars 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US84091317 mars 20072 avr. 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US84563018 mai 20084 juin 2013Abbott Diabetes Care Inc.Analyte monitoring system and methods
US84619858 mai 200811 juin 2013Abbott Diabetes Care Inc.Analyte monitoring system and methods
US846542530 juin 200918 juin 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US846797228 avr. 201018 juin 2013Abbott Diabetes Care Inc.Closed loop blood glucose control algorithm analysis
US847171430 déc. 201125 juin 2013Abbott Diabetes Care Inc.Method and system for providing data management in data monitoring system
US847302131 juil. 200925 juin 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US847322023 janv. 201225 juin 2013Abbott Diabetes Care Inc.Method and device for early signal attenuation detection using blood glucose measurements
US848058019 avr. 20079 juil. 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US851223920 avr. 200920 août 2013Abbott Diabetes Care Inc.Glucose measuring device for use in personal area network
US851224330 sept. 200520 août 2013Abbott Diabetes Care Inc.Integrated introducer and transmitter assembly and methods of use
US851224615 mars 201020 août 2013Abbott Diabetes Care Inc.Method and apparatus for providing peak detection circuitry for data communication systems
US854540328 déc. 20061 oct. 2013Abbott Diabetes Care Inc.Medical device insertion
US856008230 janv. 200915 oct. 2013Abbott Diabetes Care Inc.Computerized determination of insulin pump therapy parameters using real time and retrospective data processing
US856179515 nov. 201222 oct. 2013Seventh Sense Biosystems, Inc.Low-pressure packaging for fluid devices
US857162429 déc. 200429 oct. 2013Abbott Diabetes Care Inc.Method and apparatus for mounting a data transmission device in a communication system
US857985331 oct. 200612 nov. 2013Abbott Diabetes Care Inc.Infusion devices and methods
US858559110 juil. 201019 nov. 2013Abbott Diabetes Care Inc.Method and system for providing basal profile modification in analyte monitoring and management systems
US85931093 nov. 200926 nov. 2013Abbott Diabetes Care Inc.Method and system for powering an electronic device
US859328720 juil. 201226 nov. 2013Abbott Diabetes Care Inc.Analyte monitoring system and methods
US85971893 mars 20093 déc. 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US859757523 juil. 20123 déc. 2013Abbott Diabetes Care Inc.Analyte monitoring devices and methods therefor
US86029917 juin 201010 déc. 2013Abbott Diabetes Care Inc.Analyte sensor introducer and methods of use
US861215916 févr. 200417 déc. 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US861370329 mai 200824 déc. 2013Abbott Diabetes Care Inc.Insertion devices and methods
US861707121 juin 200731 déc. 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US862290325 mai 20127 janv. 2014Abbott Diabetes Care Inc.Continuous glucose monitoring system and methods of use
US862290621 déc. 20097 janv. 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US863822023 mai 201128 janv. 2014Abbott Diabetes Care Inc.Method and apparatus for providing data communication in data monitoring and management systems
US864161921 déc. 20094 févr. 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US864726920 avr. 200911 févr. 2014Abbott Diabetes Care Inc.Glucose measuring device for use in personal area network
US86498413 avr. 200711 févr. 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US865204320 juil. 201218 févr. 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US865397721 juin 201318 févr. 2014Abbott Diabetes Care Inc.Method and system for providing data management in data monitoring system
US866062717 mars 200925 févr. 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US866509130 juin 20094 mars 2014Abbott Diabetes Care Inc.Method and device for determining elapsed sensor life
US866646916 nov. 20074 mars 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US86686453 janv. 200311 mars 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US866904721 juil. 201111 mars 2014Theranos, Inc.Real-time detection of influenza virus
US867081530 avr. 200711 mars 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US867284427 févr. 200418 mars 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US867651321 juin 201318 mars 2014Abbott Diabetes Care Inc.Method and device for early signal attenuation detection using blood glucose measurements
US867940724 mars 200625 mars 2014Theranos, Inc.Systems and methods for improving medical treatments
US868818830 juin 20091 avr. 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US873218815 févr. 200820 mai 2014Abbott Diabetes Care Inc.Method and system for providing contextual based medication dosage determination
US873434630 avr. 200727 mai 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US873434817 mars 200927 mai 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US87381093 mars 200927 mai 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US874123030 oct. 20063 juin 2014Theranos, Inc.Systems and methods of sample processing and fluid control in a fluidic system
US87445453 mars 20093 juin 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US876465730 mars 20121 juil. 2014Abbott Diabetes Care Inc.Medical device inserters and processes of inserting and using medical devices
US876505927 oct. 20101 juil. 2014Abbott Diabetes Care Inc.Blood glucose tracking apparatus
US877118316 févr. 20058 juil. 2014Abbott Diabetes Care Inc.Method and system for providing data communication in continuous glucose monitoring and management system
US877488724 mars 20078 juil. 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US877866530 mars 201015 juil. 2014Theranos, Inc.Detection and quantification of analytes in bodily fluids
US879520128 janv. 20135 août 2014Intuity Medical, Inc.Catalysts for body fluid sample extraction
US879893423 juil. 20105 août 2014Abbott Diabetes Care Inc.Real time management of data relating to physiological control of glucose levels
US8801631 *30 sept. 200512 août 2014Intuity Medical, Inc.Devices and methods for facilitating fluid transport
US88082029 nov. 201119 août 2014Seventh Sense Biosystems, Inc.Systems and interfaces for blood sampling
US881507610 oct. 201226 août 2014Lifescan Scotland LimitedSystems and methods for determining a substantially hematocrit independent analyte concentration
US882141219 nov. 20122 sept. 2014Seventh Sense Biosystems, Inc.Delivering and/or receiving fluids
US882141320 févr. 20132 sept. 2014Roche Diagnostics Operations, Inc.System for withdrawing small amounts of body fluid
US882797126 avr. 20129 sept. 2014Seventh Sense Biosystems, Inc.Delivering and/or receiving fluids
US884055326 févr. 200923 sept. 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US884107624 mars 200623 sept. 2014Theranos, Inc.Systems and methods for conducting animal studies
US885210130 sept. 20097 oct. 2014Abbott Diabetes Care Inc.Method and apparatus for providing analyte sensor insertion
US88521242 juin 20117 oct. 2014Roche Diagnostics Operations, Inc.Tape transport lance sampler
US886219817 déc. 201214 oct. 2014Abbott Diabetes Care Inc.Method and system for providing an integrated analyte sensor insertion device and data processing unit
US886244818 oct. 201014 oct. 2014Theranos, Inc.Integrated health data capture and analysis system
US888013718 avr. 20034 nov. 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US888351830 mars 201211 nov. 2014Theranos, Inc.Systems and methods of fluidic sample processing
US891585028 mars 201423 déc. 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US891960530 nov. 201030 déc. 2014Intuity Medical, Inc.Calibration material delivery devices and methods
US892031928 déc. 201230 déc. 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US89302033 févr. 20106 janv. 2015Abbott Diabetes Care Inc.Multi-function analyte test device and methods therefor
US893366425 nov. 201313 janv. 2015Abbott Diabetes Care Inc.Method and system for powering an electronic device
US896909728 févr. 20113 mars 2015Intuity Medical, Inc.Analyte detection devices and methods with hematocrit-volume correction and feedback control
US89743861 nov. 200510 mars 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8979755 *8 déc. 200617 mars 2015The Boeing CompanyDevices and systems for remote physiological monitoring
US899333131 août 201031 mars 2015Abbott Diabetes Care Inc.Analyte monitoring system and methods for managing power and noise
US900092922 nov. 20137 avr. 2015Abbott Diabetes Care Inc.Analyte monitoring system and methods
US901133129 déc. 200421 avr. 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US901133230 oct. 200721 avr. 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US90147737 mars 200721 avr. 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US903389822 juin 201119 mai 2015Seventh Sense Biosystems, Inc.Sampling devices and methods involving relatively little pain
US903425016 sept. 201019 mai 2015Roche Diagnostics Operations, Inc.Dynamic integrated lancing test strip with sterility cover
US903576730 mai 201319 mai 2015Abbott Diabetes Care Inc.Analyte monitoring system and methods
US90399752 déc. 201326 mai 2015Abbott Diabetes Care Inc.Analyte monitoring devices and methods therefor
US904154128 janv. 201126 mai 2015Seventh Sense Biosystems, Inc.Monitoring or feedback systems and methods
US90429532 mars 200726 mai 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US90464804 mars 20132 juin 2015Lifescan Scotland LimitedMethod for determining hematocrit corrected analyte concentrations
US906072329 juil. 201423 juin 2015Intuity Medical, Inc.Body fluid sampling arrangements
US906410730 sept. 201323 juin 2015Abbott Diabetes Care Inc.Infusion devices and methods
US90666943 avr. 200730 juin 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US906669512 avr. 200730 juin 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US906669727 oct. 201130 juin 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US906670917 mars 201430 juin 2015Abbott Diabetes Care Inc.Method and device for early signal attenuation detection using blood glucose measurements
US907247721 juin 20077 juil. 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US907504624 nov. 20097 juil. 2015Theranos, Inc.Fluidic medical devices and uses thereof
US907860717 juin 201314 juil. 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US909529027 févr. 20124 août 2015Abbott Diabetes Care Inc.Method and apparatus for providing rolling data in communication systems
US909529230 juil. 20124 août 2015Intuity Medical, Inc.Analyte concentration detection devices and methods
US91138362 mars 201025 août 2015Seventh Sense Biosystems, Inc.Devices and techniques associated with diagnostics, therapies, and other applications, including skin-associated applications
US911957826 avr. 20121 sept. 2015Seventh Sense Biosystems, Inc.Plasma or serum production and removal of fluids under reduced pressure
US912185113 mai 20131 sept. 2015Theranos, Inc.Modular point-of-care devices, systems, and uses thereof
US913188416 mars 201115 sept. 2015Theranos, Inc.Medical device for analyte monitoring and drug delivery
US9133024 *2 sept. 200415 sept. 2015Brigitte Chau PhanPersonal diagnostic devices including related methods and systems
US9176126 *6 mai 20143 nov. 2015Theranos, Inc.Systems and methods of sample processing and fluid control in a fluidic system
US917745610 juin 20133 nov. 2015Abbott Diabetes Care Inc.Analyte monitoring system and methods
US91823887 janv. 201110 nov. 2015Theranos, Inc.Calibration of fluidic devices
US918609824 mars 201117 nov. 2015Abbott Diabetes Care Inc.Medical device inserters and processes of inserting and using medical devices
US921599224 mars 201122 déc. 2015Abbott Diabetes Care Inc.Medical device inserters and processes of inserting and using medical devices
US922670128 avr. 20105 janv. 2016Abbott Diabetes Care Inc.Error detection in critical repeating data in a wireless sensor system
US925917523 oct. 200616 févr. 2016Abbott Diabetes Care, Inc.Flexible patch for fluid delivery and monitoring body analytes
US926545324 mars 201123 févr. 2016Abbott Diabetes Care Inc.Medical device inserters and processes of inserting and using medical devices
US928536626 mars 201515 mars 2016Theranos, Inc.Modular point-of-care devices, systems, and uses thereof
US929541726 avr. 201229 mars 2016Seventh Sense Biosystems, Inc.Systems and methods for collecting fluid from a subject
US9303286 *22 mai 20145 avr. 2016Theranos, Inc.Detection and quantification of analytes in bodily fluids
US931419531 août 201019 avr. 2016Abbott Diabetes Care Inc.Analyte signal processing device and methods
US93141983 avr. 201519 avr. 2016Abbott Diabetes Care Inc.Analyte monitoring system and methods
US932046129 sept. 201026 avr. 2016Abbott Diabetes Care Inc.Method and apparatus for providing notification function in analyte monitoring systems
US932389815 nov. 201326 avr. 2016Abbott Diabetes Care Inc.Method and system for providing basal profile modification in analyte monitoring and management systems
US932671429 juin 20103 mai 2016Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US93267165 déc. 20143 mai 2016Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US933293329 sept. 201410 mai 2016Abbott Diabetes Care Inc.Method and apparatus for providing analyte sensor insertion
US933294431 janv. 201410 mai 2016Abbott Diabetes Care Inc.Method and system for providing data management in data monitoring system
US935166930 sept. 201031 mai 2016Abbott Diabetes Care Inc.Interconnect for on-body analyte monitoring device
US93666364 févr. 201514 juin 2016Intuity Medical, Inc.Analyte detection devices and methods with hematocrit/volume correction and feedback control
US93809715 déc. 20145 juil. 2016Abbott Diabetes Care Inc.Method and system for powering an electronic device
US938097429 sept. 20065 juil. 2016Intuity Medical, Inc.Multi-site body fluid sampling and analysis cartridge
US939888210 sept. 200626 juil. 2016Abbott Diabetes Care Inc.Method and apparatus for providing analyte sensor and data processing device
US94025441 févr. 20102 août 2016Abbott Diabetes Care Inc.Analyte sensor and apparatus for insertion of the sensor
US940257011 déc. 20122 août 2016Abbott Diabetes Care Inc.Analyte sensor devices, connections, and methods
US943579314 déc. 20116 sept. 2016Theranos, Inc.Modular point-of-care devices, systems, and uses thereof
US944575622 sept. 201020 sept. 2016Roche Diabetes Care, Inc.Dynamic integrated lancing test strip with sterility cover
US946026310 oct. 20144 oct. 2016Theranos, Inc.Integrated health data capture and analysis system
US94649815 déc. 201411 oct. 2016Theranos, Inc.Systems and methods for sample use maximization
US947781123 juin 200525 oct. 2016Abbott Diabetes Care Inc.Blood glucose tracking apparatus and methods
US948042119 août 20131 nov. 2016Abbott Diabetes Care Inc.Integrated introducer and transmitter assembly and methods of use
US948042723 avr. 20121 nov. 2016Roche Diabetes Care, Inc.Lancet
US949815930 oct. 200722 nov. 2016Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US952196830 sept. 200520 déc. 2016Abbott Diabetes Care Inc.Analyte sensor retention mechanism and methods of use
US957253428 juin 201121 févr. 2017Abbott Diabetes Care Inc.Devices, systems and methods for on-skin or on-body mounting of medical devices
US95749143 mars 201421 févr. 2017Abbott Diabetes Care Inc.Method and device for determining elapsed sensor life
US95750585 nov. 201421 févr. 2017Theranos, Inc.Systems and methods of fluidic sample processing
US958158820 août 201528 févr. 2017Theranos, Inc.Modular point-of-care devices, systems, and uses thereof
US958810927 janv. 20167 mars 2017Theranos, Inc.Modular point-of-care devices, systems, and uses thereof
US96100349 nov. 20154 avr. 2017Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US961962718 févr. 201311 avr. 2017Theranos, Inc.Systems and methods for collecting and transmitting assay results
US962541319 mai 201518 avr. 2017Abbott Diabetes Care Inc.Analyte monitoring devices and methods therefor
US96360518 juin 20092 mai 2017Intuity Medical, Inc.Detection meter and mode of operation
US963606017 déc. 20132 mai 2017Abbott Diabetes Care Inc.Dermal layer analyte sensing devices and methods
US963606824 juin 20162 mai 2017Abbott Diabetes Care Inc.Analyte sensor and apparatus for insertion of the sensor
US964905711 mai 201516 mai 2017Abbott Diabetes Care Inc.Analyte monitoring system and methods
US96686865 févr. 20146 juin 2017Abbott Diabetes Care Inc.In vivo glucose sensing in an increased perfusion dermal layer
US966916216 mars 20166 juin 2017Abbott Diabetes Care Inc.Method and system for providing basal profile modification in analyte monitoring and management systems
US96779931 juil. 201513 juin 2017Theranos, Inc.Systems and methods for sample use maximization
US968718330 mars 201227 juin 2017Abbott Diabetes Care Inc.Medical device inserters and processes of inserting and using medical devices
US969371327 juin 20164 juil. 2017Abbott Diabetes Care Inc.Analyte sensor devices, connections, and methods
US973058410 févr. 201415 août 2017Abbott Diabetes Care Inc.Glucose measuring device for use in personal area network
US973062411 juil. 201415 août 2017Seventh Sense Biosystems, Inc.Delivering and/or receiving fluids
US974386229 mars 201229 août 2017Abbott Diabetes Care Inc.Systems and methods for transcutaneously implanting medical devices
US97438631 juin 201629 août 2017Abbott Diabetes Care Inc.Method and system for powering an electronic device
US97504398 avr. 20165 sept. 2017Abbott Diabetes Care Inc.Method and apparatus for providing notification function in analyte monitoring systems
US975044012 avr. 20165 sept. 2017Abbott Diabetes Care Inc.Method and system for providing data management in data monitoring system
US975044427 avr. 20165 sept. 2017Abbott Diabetes Care Inc.Interconnect for on-body analyte monitoring device
US97722911 juin 201526 sept. 2017Theranos, Inc.Fluidic medical devices and uses thereof
US977555113 juil. 20153 oct. 2017Seventh Sense Biosystems, Inc.Devices and techniques associated with diagnostics, therapies, and other applications, including skin-associated applications
US977556321 sept. 20163 oct. 2017Abbott Diabetes Care Inc.Integrated introducer and transmitter assembly and methods of use
US97821143 août 201210 oct. 2017Intuity Medical, Inc.Devices and methods for body fluid sampling and analysis
US978877123 oct. 200617 oct. 2017Abbott Diabetes Care Inc.Variable speed sensor insertion devices and methods of use
US979533128 avr. 201624 oct. 2017Abbott Diabetes Care Inc.Method and apparatus for providing analyte sensor insertion
US980154530 juil. 201531 oct. 2017Abbott Diabetes Care Inc.Method and apparatus for providing rolling data in communication systems
US980818626 sept. 20147 nov. 2017Abbott Diabetes Care Inc.Method and system for providing an integrated analyte sensor insertion device and data processing unit
US20020137998 *26 mars 200126 sept. 2002Wilson SmartSilicon microprobe with integrated biosensor
US20030018282 *30 août 200123 janv. 2003Carlo EffenhauserSystem for withdrawing small amounts of body fluid
US20040193072 *11 juin 200330 sept. 2004Allen John J.Method of analyte measurement using integrated lance and strip
US20050049522 *29 oct. 20033 mars 2005Allen John JMethod of lancing skin for the extraction of blood
US20050059166 *11 sept. 200317 mars 2005Robert MarkesSampling instrument
US20050106713 *2 sept. 200419 mai 2005Phan Brigitte C.Personal diagnostic devices and related methods
US20050187525 *19 févr. 200425 août 2005Hilgers Michael E.Devices and methods for extracting bodily fluid
US20050217741 *30 mars 20056 oct. 2005Sebastian BohmMethod of controlling the movement of fluid through a microfluidic circuit using an array of triggerable passive valves
US20050217742 *30 mars 20056 oct. 2005Sebastian BohmMicrofluidic circuit including an array of triggerable passive valves
US20050217743 *30 mars 20056 oct. 2005Sebastian BohmTriggerable passive valve for use in controlling the flow of fluid
US20050220629 *30 mars 20056 oct. 2005Sebastian BohmMethod of segregating a bolus of fluid using a pneumatic actuator in a fluid handling circuit
US20050220630 *30 mars 20056 oct. 2005Sebastian BohmMethod of using triggerable passive valves to control the flow of fluid
US20050220644 *30 mars 20056 oct. 2005Sebastian BohmPneumatic actuator for bolus generation in a fluid handling circuit
US20050284773 *29 juin 200429 déc. 2005Allen John JMethod of preventing reuse in an analyte measuring system
US20060000710 *30 juin 20045 janv. 2006Klaus Peter WeidenhauptFluid handling methods
US20060004303 *30 juin 20045 janv. 2006Weidenhaupt Klaus PFluid handling devices
US20060030789 *14 oct. 20059 févr. 2006Allen John JIntegrated lance and strip for analyte measurement
US20060062852 *12 août 200523 mars 2006Holmes Elizabeth AMedical device for analyte monitoring and drug delivery
US20060074351 *20 sept. 20056 avr. 2006Allen John JIntegrated lance and strip for analyte measurement
US20060182738 *12 août 200517 août 2006Holmes Elizabeth AMedical device for analyte monitoring and drug delivery
US20060200045 *2 mars 20057 sept. 2006Roe Steven NDynamic integrated lancing test strip with sterility cover
US20060264779 *24 mars 200623 nov. 2006Kemp Timothy MFluidic medical devices and uses thereof
US20060264780 *24 mars 200623 nov. 2006Holmes Elizabeth ASystems and methods for conducting animal studies
US20060264782 *24 mars 200623 nov. 2006Holmes Elizabeth APoint-of-care fluidic systems and uses thereof
US20060264783 *24 mars 200623 nov. 2006Holmes Elizabeth ASystems and methods for monitoring pharmacological parameters
US20070078313 *30 sept. 20055 avr. 2007Rosedale Medical, Inc.Fluid sample transport devices and methods
US20070167869 *20 oct. 200619 juil. 2007Roe Steven NSystem and method for breaking a sterility seal to engage a lancet
US20070224084 *30 oct. 200627 sept. 2007Holmes Elizabeth ASystems and Methods of Sample Processing and Fluid Control in a Fluidic System
US20070232876 *31 mars 20064 oct. 2007Erik OttoDiabetes management methods and systems
US20070232956 *13 sept. 20054 oct. 2007Microsample Ltd.Method and Apparatus for Sampling and Analysis of Fluids
US20070264629 *9 mai 200715 nov. 2007Holmes Elizabeth AReal-Time Detection of Influenza Virus
US20070276211 *29 mai 200729 nov. 2007Jose MirCompact minimally invasive biomedical monitor
US20080009766 *24 mars 200610 janv. 2008Holmes Elizabeth ASystems and methods for improving medical treatments
US20080009767 *20 sept. 200710 janv. 2008Roche Diagnostics Operations, Inc.System for withdrawing small amounts of body fluid
US20080097171 *30 oct. 200724 avr. 2008Wilson SmartSilicon microprobe with integrated biosensor
US20080103415 *13 oct. 20061 mai 2008Roe Steven NTape transport lance sampler
US20080139894 *8 déc. 200612 juin 2008Joanna Szydlo-MooreDevices and systems for remote physiological monitoring
US20080154107 *20 déc. 200626 juin 2008Jina Arvind NDevice, systems, methods and tools for continuous glucose monitoring
US20080234562 *19 mars 200725 sept. 2008Jina Arvind NContinuous analyte monitor with multi-point self-calibration
US20080312518 *14 juin 200718 déc. 2008Arkal Medical, IncOn-demand analyte monitor and method of use
US20090007631 *2 août 20048 janv. 2009Daikin Industries, Ltd.Oxygen Electrode
US20090082652 *25 sept. 200726 mars 2009Pacesetter, Inc.Implantable body fluid analyzer
US20090082693 *29 déc. 200426 mars 2009Therasense, Inc.Method and apparatus for providing temperature sensor module in a data communication system
US20090093697 *11 août 20089 avr. 2009Jose MirMems interstitial prothrombin time test
US20090099478 *13 mars 200716 avr. 2009Microsample LtdMethod and apparatus for piercing the skin and delivery or collection of liquids
US20090131778 *20 nov. 200821 mai 2009Jina Arvind NDevices, systems, methods and tools for continuous glucose monitoring
US20100023045 *16 juil. 200728 janv. 2010Heinz MachoLancet, Lancet Supply Ribbon, and Puncturing Device for Generating a Puncturing Wound
US20100049021 *20 août 200925 févr. 2010Jina Arvind NDevices, systems, methods and tools for continuous analyte monitoring
US20100074799 *24 nov. 200925 mars 2010Kemp Timothy MFluidic Medical Devices and Uses Thereof
US20100081144 *8 oct. 20091 avr. 2010Theranos, Inc.Point-of-care fluidic systems and uses thereof
US20100100005 *5 févr. 200722 avr. 2010Infotonics Technology Center, Inc.Minimally invasive allergy testing system with coated allergens
US20100219084 *5 oct. 20072 sept. 2010Stephen Patrick BlytheMethod for determining hematocrit corrected analyte concentrations
US20100248277 *30 mars 201030 sept. 2010Ian GibbonsDetection and quantification of analytes in bodily fluids
US20100292551 *27 juil. 201018 nov. 2010Jina Arvind NDevices, systems, methods and tools for continuous glucose monitoring
US20100324401 *10 août 201023 déc. 2010Lifescan, Inc.Diabetes management methods and systems
US20110000168 *16 sept. 20106 janv. 2011Roe Steven NDynamic integrated lancing test strip with sterility cover
US20110004084 *17 sept. 20106 janv. 2011Abbott Diabetes Care Inc.Method of Calibrating an Analyte-Measurement Device, and Associated Methods, Devices and Systems
US20110098599 *31 déc. 201028 avr. 2011Intuity Medical, Inc.Fluid Sample Transport Devices and Methods
US20110104826 *7 janv. 20115 mai 2011Ian GibbonsCalibration of fluidic devices
US20110162978 *22 janv. 20107 juil. 2011Lifescan Scotland Ltd.Systems and methods for determining a substantially hematocrit independent analyte concentration
US20110166553 *16 mars 20117 juil. 2011Holmes Elizabeth AMedical device for analyte monitoring and drug delivery
US20110178435 *29 mars 201121 juil. 2011Roe Steven NSystem and method for breaking a sterility seal to engage a lancet
US20110230905 *2 juin 201122 sept. 2011Roche Diagnostics Operations, Inc.Tape transport lance sampler
US20120022352 *4 oct. 201126 janv. 2012Masaki FujiwaraBlood sensor, blood testing apparatus, and method for controlling blood testing apparatus
US20120323097 *1 juil. 200920 déc. 2012Nemaura Pharma LimitedPatch for reverse iontophoresis
US20140154708 *11 juin 20135 juin 2014Theranos, Inc.Reducing optical interference in a fluidic device
US20150182157 *30 déc. 20132 juil. 2015CardioCanary, Inc.On-Patient Autonomous Blood Sampler and Analyte Measurement Device
US20160058354 *14 sept. 20153 mars 2016Life Patch International, Inc.Personal diagnostic device having a fluidic circuit with a plurality of analysis chambers
US20160066828 *14 sept. 201510 mars 2016Life Patch International, Inc.Personal diagnostic device having an air sample collection unit and a fluidic circuit
EP1869414A2 *28 mars 200626 déc. 2007Arkal Medical, Inc.Devices, systems, methods and tools for continuous glucose monitoring
EP1869414A4 *28 mars 200628 juil. 2010Arkal Medical IncDevices, systems, methods and tools for continuous glucose monitoring
EP2083878A2 *22 oct. 20075 août 2009Abbott Diabetes Care, Inc.Flexible patch for fluid delivery and monitoring body analytes
EP2083878A4 *22 oct. 200728 avr. 2010Abbott Diabetes Care IncFlexible patch for fluid delivery and monitoring body analytes
EP2924439A125 mars 201130 sept. 2015Mycartis N.V.Ltbp2 as a biomarker for predicting or prognosticating mortality
EP2967460A4 *5 févr. 201419 oct. 2016Abbott Diabetes Care IncIn vivo glucose sensing in an increased perfusion dermal layer
WO2006030201A113 sept. 200523 mars 2006Microsample Ltd.Method and apparatus for sampling and analysis of fluids
WO2006105146A228 mars 20065 oct. 2006Arkal Medical, Inc.Devices, systems, methods and tools for continuous glucose monitoring
WO2006114649A116 mars 20062 nov. 2006Bio-Nano Sensium Technologies LimitedSensor configuration
WO2007041063A3 *26 sept. 20069 août 2007Jeffrey L EmeryFluid sample transport devices and methods
WO2008043565A2 *12 oct. 200717 avr. 2008Roche Diagnostics GmbhTape transport lance sampler
WO2008043565A3 *12 oct. 20073 juil. 2008Roche Diagnostics GmbhTape transport lance sampler
WO2009081404A1 *25 déc. 20082 juil. 2009Medingo Ltd.System and method for glycemic control
WO2010086380A128 janv. 20105 août 2010Pronota N.V.Biomarker for diagnosis, prediction and/or prognosis of acute heart failure and uses thereof
WO2011048168A121 oct. 201028 avr. 2011Pronota N.V.Biomarker for diagnosis, prediction and/or prognosis of acute heart failure and uses thereof
WO2011048173A121 oct. 201028 avr. 2011Pronota N.V.Mcam as a biomarker for fluid homeostasis
WO2011128357A213 avr. 201120 oct. 2011Pronota N.V.Biomarkers for hypertensive disorders of pregnancy
WO2014143452A15 févr. 201418 sept. 2014Abbott Diabetes Care Inc.In vivo glucose sensing in an increased perfusion dermal layer
WO2017139084A1 *23 janv. 201717 août 2017Applied Materials, Inc.Medical bodily fluid sampling device
Classifications
Classification aux États-Unis435/287.2
Classification internationaleA61B5/151, A61B5/00, A61B5/15, G01N33/49, A61B5/1468, A61B10/00, G01N27/22, G01N33/86, G01N27/02
Classification coopérativeA61B5/150755, A61B5/15045, A61B5/15142, A61B5/150419, A61B5/150213, A61B5/150022, A61B5/150358, A61B5/1473, A61B10/0045, A61B2010/008, A61B5/14514
Classification européenneA61B5/1473, G01N33/49B, G01N27/02, A61B10/00L, G01N27/22B
Événements juridiques
DateCodeÉvénementDescription
8 déc. 2003ASAssignment
Owner name: INVERNESS MEDICAL LIMITED, SCOTLAND
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:STIENE, MATTHIAS;RICHTER, TANJA;ALLEN, JOHN;AND OTHERS;REEL/FRAME:014772/0159;SIGNING DATES FROM 20030624 TO 20030715